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BIOTECHNOLOGY AND THIRD WORLD FARMING SYSTEMS(}) 
Introduction 
Agrjculture is on the verge of a technological revolution that will 
transform farming as much or more than any other group of technologies 
introdnced to the farmer. Propelling this "biorevolution" in agriculture are 
the dramatic new advances in cellular and molecular biology that have been 
achieved in the research universities of the developed countries. Yet the 
social and economic implications of these new techniques for manipulating 
living organisms are only beginning to be understood (see Appendix 1). The 
importance of the new biotechnologies is such that decisionmakers in the Third 
World countries (TWCs) must develop strategies to ensure that their countries 
are not once again left hopelessly dependent on technology that must be 
imported from abroad at exorbitant prices. Action must be taken quickly 
because biotechnology and, generally, the basic biological sciences are 
advancing very rapidly. It is said by biologists that within ten years the 
entire human genome will be mapped (Gefter 1984)--a crucial step in engin-
eering human beings. Clearly, we are only glimpsing the dawn of the 
biorevolution. 
This document will provide an overview of the structure of the bio-
technology industry in the developed countries (DCs) and then proceed to an 
analysis of the areas of potential impact on the TWCs. The initial section 
briefly documents the growth of the U.S. biotechnology industry. The U.S. is 
the focus because of its tremendous size and importance as the world pace-
setter in biotechnology. The trend to privatize research results not only in 
the U.S., but in all advanced industrial countries could lead to an environ-
ment in which LDCs are unable to secure access to information important to the 
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success of their national biotechnology efforts.<2) The final section will 
outline the types of policies LDCs can undertake to ensure their participation 
in the biorevolution on their own terms and not those dictated by outside 
entities such as the transnational chemical/pharmaceutical companies (TNCs). 
It must be recognized from the outset that a country desiring to participate 
actively in the bierevolution and not merely as a passive recipient must be 
willing to make difficult investment decisions and persevere. 
Biotechnology is an array of tools that can be applied in a number of 
industries. In fact, any industry that involves living or dead organic matter 
could be affected. Thus, the industries prominently featured as being 
beneficiaries of biotechnology include: energy, chemicals, pharmaceuticals, 
waste management, and agriculture. Each of these industries is carbon-based 
and, in fact, biotechnology will contribute to the greater interlinkage of 
these industries. Thus, developments in one industry will affect the other 
industries. For example, suppose there is research success in fermenting 
energy from agricultural wastes. This would impact the energy sector and the 
economics of food production. There are numerous and complex interlinkages in 
these industrial branches and biotechnology provides techniques for 
addressing problems in each of these various industries. 
The new scientific techniques that are included in biotechnology offer 
mankind the possibility of controlling and directing evolution itself (Rifkin 
1983). There can be no doubt that biotechnology will make agriculture more 
productive than ever. Yet increased productivity is not an end in itself. 
Will this increased productivity benefit those too poor to be able to purchase 
the output? And, as importantly, will those TWC agricultural producers who 
are among the world's poorest be able to take advantage of these newest 
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techniques developed by Twentieth Century science? The answer to these 
questions depends on a number of variables outside the control of the hie-
technologists. 
This monograph will demonstrate the impacts will be contradictory--
biotechnology could increase farmers' productivity, conversely it could 
operate to entirely displace the commercial demand for that identical crop. In 
the develop~d countries farmers will plant biotechnologically-engineered seeds 
at a moment which is selected by an optimization program run on their micro-
computer linked via satellite or telephone to an on-line data base. Increas-
ingly, the providers of these services will shift from public agencies 
(departments of agriculture or public universities) to commercial entities 
(for-profit corporations) many of which will be transnational in scope.(3) 
What will TWC agriculture look like in the year 2000? 
It is necessary for me to briefly state my personal position on the 
desirability of the coming "biorevolution." For TW biotechnology could be 
devastating by displacing export markets, displacing peasant farmers by 
crP.ating new commercial farms, and increasing TW dependence on transnational 
corporations. The other possibility is the TWCs do everything possible to 
embrace biotechnology and adapt it to their unique needs. Biotechnology can be 
done at many levels from capital-intensive to labor-intensive. Irregardless, 
Third World laboratories will be the front lines in the struggle to overcome 
dependence. At least some TWC problems can be tackled using the techniques 
and tools developed by biotechnology and available in TWCs. It would be a 
certain mistake to attempt to mtmic the research and activities underway in 
developed countries without developing a well planned realistic action 
program. The potential of biotechnology is best summed up by the Chinese 
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character for opportunity--an amalgamation of the characters for danger and 
reward: Both exist in biotechnology. 
Any productive force of the power and magnitude of biotechnology will 
necessarily have tremendous influences and impacts on social systems. There 
will be winners and losers, but no group is necessarily "fated" to be a loser. 
Being a loser will depend on the outcomes of the strategies a group, country, 
or group of countries adopt to ensure that they secure their rightful share of 
the benefits. It should be born in mind that choosing not to participate in 
the biorevolution is not a viable strategy because the impacts cannot be 
avoided. The biorevolution will affect even the most isolated societies. 
The beauty of biotechnology is that it has many levels of sophistication 
from the ultrahigh technology of the MIT biology department with its multi-
million dollar budget to the family-size tissue culture laboratories of 
Vietnam (Uyen 1984). Many of the ultrasophisticated modern techniques can be 
reduced to relatively low cost operations without losing all possibility of 
success. Clearly, U.S. research laboratories and family-size tissue culture 
laboratories are aiming at very different goals, but this is precisely the 
point--TWCs must aim at targets that are within reach--the choosing of 
achievable targets is of central importance. 
The Agricultural Biotechnology Industry in the Developed Countries 
Investments in agricultural biotechnology came somewhat later than those 
in the biomedical area. In the period from 1979 to 1983 plant molecular and 
cellular biologists followed their medical colleagues and quickly became 
involved in forming new biotechnology firms (NBFs) with names such as, 
Advanced Genetic Sciences, Calgene, Plant Genetics, DNA Plant Technologies, 
Phytogen, Molecular Genetics, and Sungene. Other new biotechnology firms 
5 
(NBFs) such as Cetus, Genentech, Biogen, and Biotechnica International also 
launched certain agriculturally-related R & D programs. Another group of 
companies the large multinational agribusiness pharmaceutical/chemical 
companies (MNCs) with big investments and large marketing networks in agri-
cultural chemicals and seeds also showed interest in what biotechnology could 
do for their operations. 
As has been documented for the general biotechnology industry (Kenney 
forthcoming), the agricultural biotechnology industry began on the basis of 
the expertise university professor had developed in their campus laboratories. 
Agricultural scientists whose research had been funded by U.S. government 
agencies were approached by or approached entrepreneurs who were seeking the 
scientific expertise necessary to launch NBFs. In return for his services the 
university scientist, usually a senior professor, receives a significant 
equity position in and was put on retainer of the fledgling company. With 
this partnership the new company is launched and the quest for capital and 
products commences. 
Capital is a critical requirement for these companies because the major 
products of biotechnology will not be immediately available. In fact, the 
typical company will operate for five to ten years before producing its first 
important product.(4) In 1980 the start-up costs for a non-agricultural NBF's 
first three years were estimated to be approximately $10-12 million and a 
staff consisting of at least 25 Ph.Ds. The scale-up of R&D to production and 
the necessary marketing network could be an order of magnitude more expensive 
(Schneider 1980:72). However, some agricultural operations have been 
launched with less investment. For example, Molecular Genetics, Inc., a 
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promin~nt agricultural NBF had only 114 employees and assets of $33 million 
(Molecular Genetics 1984). 
Obviously, such sums of capital are not available to th~ av~rage pro-
fessor and securing sufficient funding has requir~d the NBFs to tap a number 
of financial sources. The initial source of capjtal for many NBFs were the 
venture capital funds that specialize in providing start-up funds to new 
companies in return for a share of the new company's equity. These venture 
capitalists evaluate the company's business plan and assist in the recruit-
ment of the necessary managers, lawyers, and accountants that will provide the 
managerial base so necessary to ensure the young companies survival. These 
financiers have no commitment to the company and are investing for the sole 
purpose of securing a large capital gain upon sale of their equity interest. 
The venture capitalists, however, cannot fund an NBF alone and it must 
seek other fund sources. The two most common sources of increased capital are 
stock offerings and research contracts. Stock offerings induce th~ public to 
accept part of the risk of the company on the promise of stock appreciation. 
Research contracts between MNCs and NBFs are another method of securing th~ 
needed funds to pay for research. The NBF is forced to sign such contracts 
because having no products it has few alternative sources of capital. The 
goal of the MNC is to secure a genetically engineered product or scientific 
information from the smaller company. The research contracts signed with MNCs 
place the NBF in the uncomfortable position of selling the knowledge crucial 
for its survival to its competitors. 
The key to the NBFs' success is the personnel that it retains on staff 
and its consultants in the universities (for example, Table 1 indicates the 
members of MIT's biology department linked to small biotechnology companies. 
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ThP MNCs in only very few cases have managed to recruit scientists of com-
parable quality to those NBFs have secured. Robert Luciano, now president of 
Schering-Plough, said when speaking of Biogeo's scientists, "You just couldn't 
hire people like that to work in industrial settings." (Bvlinsky 1980:152). A 
similar situation exists in agricultural biotechnology where the small start 
ups have succeeded in hiring top scientists. For example, Table 2 identifies 
Agrigenetics' university scientist consultants. 
A unique feature of the U.S. biotechnology scene has been the rapid 
development and important role of the NBFs. The key institution in the 
formation of the NBFs has been the university--the location of both the 
trained personnel and the necessary knowledge. The dependence of these 
companies on basic research skills is demonstrated by the fact the the NBFs 
have clustered around the major biological research universities of Boston and 
the San Francisco Bay Area, with the agricultural biotechnology firms clus-
tered in Davis, California and Madison, Wisconsin. 
The University and Agricultural Biotechnology 
The biotechnology industry was born in molecular biology research 
laboratories located in research universities and medical schools. Thus, 
"basic" biological research had emphasized medical applications and the 
majority of the U.S. agricultural universities had not channeled funds into 
basic research, especially in plant molecular and cellular biology. As a 
result there were few plant molecular biologists available in the agricultural 
universities and, in fact, many of the top "basic" plant biologists were 
located in universities not traditionally associated with agriculture such as 
Harvard University, the Massachusetts Institute of Technology, Stanford 
University, California Institute of Technology, and Rockefeller University. 
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This lack of expertise in plant molecular biology has contributed to the 
shortage of personnel as companies have rushed to hire agricultural bio-
technologists. 
The university is a very special institution in any society because it 
trains the skilled labor force of the society and does much of the basic 
research from which new productive forces are derived. The information 
derived from this research has traditionally been communicated openly to all 
interested in acquiring the knowledge. This openness has provided access to 
science that is unavailable from private companies. The free flow of infor-
mation and lack ot pecuniary motive has allowed scientists and students from 
any country to come and learn in a relatively open and free environment and 
has provided a medium for technology transfer to TWCs. 
The impending biorevolution in agriculture has had numerous implications 
for the agricultural universities. First, large numbers of the best 
researchers in areas of potential agricultural applications have been lured to 
join biotechnology companies. Many of the remainder of the professors that 
have not left the university entirely have joined company scientific advisory 
boards and have received stock options and other benefits. Thus, at the 
professorial level many researchers are now linked by financ]al bonds to 
private enterprises. In some cases it may no longer be clear whether a 
professor from a U.S. university is speaking as a professor or as a corporate 
owner (Kenney forthcoming). President Giamatti (1982:1279) of Yale University 
summarizes this contradiction thus: 
The burden of mounting a teaching program and two separate research 
programs (one in the company and one in the university) where the results 
of one research program are to be widely disseminated and the results of 
the other may have to be kept secret in the pursuit of commercial 
success, is more than even the most responsible faculty member can be 
expected to shoulder. 
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The jmpliration for LDCs seeking expertise in agricultural biotechnologv are 
clear--at this time in the lJ.S. especiallv, but in most developed countries 
(and in many developing countries) scientists may suffer from conflicts of 
interPst as corporate employees. 
University administrations have responded to the phenomenon of university 
professors as corporate principals by attempting to secure• corporate monies 
for the university and capturing overhead. So, for examp]e, the University of 
Illinois created a center for plant biology to be funded by Sohio, the large 
oil multinational.(5) Sohio's researchers will have access to this center and 
will have special patent privileges. In this particular case, for $2 million 
Sohio has purchased a "captive" agricultural research team in a publicly 
funded university. University administrators were involved in every aspect of 
the creation of the center and gave their blessing to this relationship. 
Other universities have allowed professors to receive funding from companies 
such as Agrigenetics and signed contracts containing provisions for the 
maintenance of trade secrecy regarding university-made discoveries. 
If it be thought that U.S. institutions are alone in this rush to 
privatize public research, the case of the Australian Natlonal University 
(ANU) is instructive. Agrigenetics is patenting a new ANll-developed soybean 
variety that can fix up to thirty-five times as much nitrogen as currently 
available varieties. The ANU research team received from Agrigenetics $2.2 
million in research funding over four years, in return Agrigenetics secured 
exclusive worldwide rights except in Australia to any varieties developed by 
the research team. The benefits of this variety is that the new soybean fixs 
more nitrogen thus less commercial nitrogen need be applied, there is less 
nitrogen runoff, and less stress on the soil structure (ANU Reporter 1984). 
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This recent development was made by random mutation methods, a less sophis-
ticated biological technique--the new biotechnologies should provide even more 
advances. Will this new development or others be available to soybean growers 
in LDCs? The answer is obvious--only if they can pay for it. 
In the publicly-supported agricultural universities plant breeders have 
traditionally bred crop plants and freely released their varieties for public 
use. The public role extended from basic plant research to the applications 
of the knowledge. However, recent criticisms have arisen that agricultural 
researchers are only involved in mere maintenance work in response to farmers' 
needs and not doing "basic," i.e., noncommercial research. This applied focus 
has until recently not been a topic of debate, but rather been hailed as a 
model upon which to build the agricultural systems. Now U.S. policy makers are 
questioning the model (Rockefeller Foundation 1983; National Academy of 
Sciences 1984). 
The publicly-funded agricultural universities also are receiving new 
competitors in terms of which universities are doing plant-related research. 
Increasingly, universities such as Harvard, Washington, and Rockefeller are 
becoming centers for plant-related basic research. Over the next twenty years 
it seems likely that only the strongest public agricultural universities will 
remain important in plant biotechnology research. And, in fact, a recent 
report issued by the White House and the Rockefeller Foundation (1983), 
Science for Agriculture, advocates centralizing of all agricultural research, 
while encouraging agriculturally-related research in universities not tradi-
tionally associated with agricuJtur~. This centralization could lead to a 
more easily managed and controlled research agenda, in which issues advocated 
by powerful groups such as farmers could be more easily ignored. There seems 
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littl~ doubt that the implementation of the new proposals will increase the 
role of the MNCs in determining the research ~genda and, in fact, their 
spokesmen have lobbied strenuously this centralization (Hardy 1982). 
The Multinational ~orporations, Agriculture, and Biotechnology 
The new biotechnologies emerged at a very propitious moment for the 
world's chemical/pharmaceutical compani~s, many of whom have been exper-
iencing a pronounced profit dip (Kenney forthcoming:300) and a slowing of the 
rate of new drug and chemical discoveries (St~ward and Wibberley 1980). For 
these MNCs biotechnology was a new technique promising to yield lucrative new 
commercial opportunities.(6) Biotechnology is an important technological 
spearhead in the ongoing drive by these MNCs to abandon commodity chemicals 
and move into specialty and agricultural chemicals. As an aspect of this 
strategy and to strengthen their position in agrichemicals the MNCs have been 
purchasing seed companies (Mooney 1979, Kloppenburg and Kenney 1983). The 
reason for these purchases are clear: The seed contains the DNA program that 
living plant follows, i.e., the seed contains all of the valuable traits of 
the grown plant such as stress tolerance, plant morphology, yield potential, 
and responses to agrichemical inputs. The importance of controlling the seed 
industry is that seed research may yield chemical-seed packages in which a 
farmer purchasing a seed could be locked into certain chemical propri~tary 
chemicals, thus ensuring the company its all-important chemical market. For 
example, Ciba-Geigy markets a sorghum seed-chemical package in the Sudan. The 
seed is coated with a patented "safener'' to protect it from Ciba-Geigy's 
patented herbicides (Farm Chemical 1979:55). 
Seed company purchases are also justified on the basis that new bio-
technological techniques will improve techniques for producing hybrids whose 
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progeny are reproductively unstable and cannot be replanted by the farmer. 
This ensures that the farmer returns to the seed company annually for the seed 
and thereby creating a market. The best example of a company that success-
fully markets hybrid seed is Pioneer--a company that consistently has a very 
high return on equity (Kloppenburg and Kenney 1983). Finally, surcessful 
hybridization of wheat and rice may open enormous new markets for MNC seed 
subsidiaries. 
Obviously, intense biotechnological research is going into creating new 
seeds. In addition to investment in seed company subsid1aries, MNCs are also 
making large investments in and funding agricultural research by the NBFs (see 
Table 3). For example, Monsanto has made major investments in a variety of 
product areas (see Table 4). In addition to investments in NBFs and univer-
sity research MNCs are building large in-house research facilities (see Table 
5). The MNCs feel that they must be at the forefront of biotechnology 
research due to its possible impacts on products they already market. 
Monsanto, Dupont, and the other MNCs are also aware that breakthroughs in 
biotechnology could make their products obsolete. For example, many companies 
are searching for a gene to clone into crop plants that will confer pesticide-
resistance to crop plants. 
The research agenda these corporate dollars are reinforcing in the 
world's research universities is one based on the necessity of making profits. 
Corporate support for biotechnological research is greatest in the U.S., but 
increasing numbers of scientists and universities in other countries are also 
receiving corporate support. This growing trend does not augur well for the 
role of these institutions in transferring knowledge to TWCs or for poor 
farmers who will be unable to purchase the new inputs from the university's 
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corporate sponsors. In all likelihood, the products ot biotechnology will be 
otf~r@o to l.DCs for purchasP at monopoly prirPs in a simjl~r mannPr as ocrurs 
rurrently in the pharmarPutical industrv. Th~ manufartur1ng knowledge will 
either be hidden as a trade secret or patented and inaccessible for use bv LDC 
producers. It should also be assumed that DC governments will assist in 
prPventing LDCs from using the patented inventions. 
Th~ Biotechnology Industry in Developed Countries--A Summation 
The creat1on of the bjotechnology industry is the story of the priva-
tization of publicly funded research--a process in which both professors and 
administrators took part. Even now, professors normally assumed to be working 
for the public good are, also, private employees. As a result of this new 
orientation professors may skew their research in directions favored by their 
private patrons. For other groups in society these directions may be less 
desirable. For example, will a researcher receiving Monsanto funds try to 
develop a new plant variety that has less need of herbicides? Or will that 
researcher develop plants that are Roundup-tolerant so as to enable farmers to 
use ever greater doses of Monsanto's proprietary herbicide, Roundup. Quite 
similarly, will corporate-funded university researchers examine techniques to 
increase yield without hybridization or will hybridization be the goal? The 
setting of research goals in biotechnology will become an increasingly 
important political and social issue. 
The description in this section has focused on the developments in the 
U.S. In Europe and Japan the home MNCs have also been very active in con-
ducting research and nearly all have signed contracts with U.S. NBFs. 
However, non-U.S. universities have not been quite as entrepreneurial as those 
in the U.S. European professors also have been more reticent to join com-
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panies. Professors in publicly supported Japanese universities are forbidden 
to join companies. Nevertheless, the entrepreneurial fever is also evident in 
Europe and Japan. 
The scenario that this section has developed appears grim for developing 
countries wishing to develop expertise in biotechnology, but there are still 
methods of securing information and expertise. Perhaps, the most important 
aspect of this section is that it provides an understanding of the social 
arrangements that have evolved in the U.S. especially, and more generally, in 
the developed countries. The next section of the paper examines the effects 
the biorevolution will have on LDCs. The fact that biotechnology will have 
countless and contradictory aspects is acknowledged, but for the purposes of 
an orderly treatment the agricultural areas of greatest interest are divided 
into four areas: 1) plant genetic manipulation and crop improvement, 2) 
industrial tissue culture, 3) animal applications of embryology and geneti-
cally engineered products, and 4) the use of genetically engineered micro-
organisms to produce or displace agricultural products. 
The Biorevolution in Third World Agriculture 
As indicated earlier the biorevolution will have four major axes of 
impact on LDC agriculture and under each axis a number of specific products 
and processes are subsumed. In fact, in some cases biotechnology could have 
contradictory influences on the very same product. For example, a higher 
yielding soybean could be produced by one group of scientists and another 
research group could develop a more efficient single cell protein production 
process creating a commercial competition between the two protein production 
processes. It is necessary for every country to become more awarP of the 
implications of the new technologies for its economy so as to take measures to 
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position itself to b~nefit from the new opportunities and to undertake 
defensive mPHsurPs whPrP nPerled. 
The biorevolution will not be immediate, but rather will unfold gradually 
as new products are developed and deployed in increasing numbers. For 
example, Genecol, an anti-scours vaccine for calves, is already available, 
while corn plants that fix their own nitrogen are at least five to ten years 
in the future (Fox 1984). This section, in describing the universe of 
possibilities, will discuss products currently available and others that will 
be developed in the much more distant future. Concomitantly, observations 
regarding the social impacts are extrapolated from studies of previous 
introductions of innovations and are meant to pose questions for policymakers. 
It is, perhaps, too early to supply answers. 
The final concern addressed is the increasingly important role of private 
enterprise in the global biotechnology market. Can TWCs be assured that their 
agricultural needs will be met through the research financed and conducted by 
these companies? Moreover, even if products were produced to meet Third World 
needs, would the importation of these products be socially desirable? The 
problem of biotechnology being used to reinforce dependence and underdevelop-
ment is posed starkly because of the tremendous possibility biotechnology 
represents for overcoming dependence. 
Plant Genetic Manipulation and Crop Improvement 
In agriculture, biotechnology's brightest promise is to provide tech-
niques for increasing crop plant yields especially coarse grains and legumes 
which provide the buJk of the world's food. The success of modern plant 
breeding in increasing crop yields over traditional varieties is well-
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documented (Table 6).(7) An important example of the impacts of plant 
breeding success in TW environments has been the success of high vie1ding rice 
and wheat varieties in increasing production. However, in the last five yPars 
for the important grajn crops, i.e., rice, wheat, and corn, there is reason to 
believe that decreasing returns to traditional plant breeding have been 
reached (Fox 1984).(8) Regardless of the actual facts about the rate of yield 
increase biotechnology is being touted as a method for drastically increasing 
the rate of growth in agricultural output. M. S. Swaminathan (1982), Director 
General of the International Rice Research Institute, lists the possible 
applications of biotechnology reseArch to rice improvement in Table 7. Other 
research is underway to develop plants better able to survive on soils 
deficient in certain trace minerals. The various biotechniques provide a 
plethora of new tools with which applied plant scientists can produce new 
improved plants. 
The Green Revolution was largely carried out by public or quasi-public 
institutions, such as, national breeding programs and the international 
agricultural research centers (IARCs). The motive of the research was not 
private profit, but rather increased food production. This is not to say that 
there were no other motives. It is very clear that the blocking of revolu-
tionary movements was an important concern (Cleaver 1972). IrregardlPss, the 
fact that these institutions were public or quasi-public made them much more 
vulnerable to public pressure for changes in research agenda. The IRRI's 
shifting staff and resources to studies of upland rice and Azolla nitrogen 
fixation program in response to its critics is an example. The nonprofit 
status of the !ARCs did not interfere with corporate objectives becausP seeds 
did not provide a very large market in TWCs. 
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Duing thP last fifteen vears the MNCs lack of interest in seeds hegan to 
change du~ to thP establishment of plant variety protecti<ln laws. Plant 
variPty protection providert breeders wjth patent-like rights to any varieties 
thPy dPveloped by precluding other companies from selling exact copies of 
their varieties. This provided the needed incentive for agrichemical pro-
ducers to join the seed industry and thereby complete a horizontal integration 
of non-durable farm producer goods inputs (Table 8). 
The development of new biotechnologies has quickened the pace of seed 
company acquisition. As seen earlier in Tables 3 and 5 the MNCs have made 
major investments in agricultural biotechnology. These companies believe that 
biotechnology offers a tool to effectively wed their agrichemicals to the 
seed. This will not only secure synergies, but ideally would ensure that the 
farmer purchase an entire input package from the company. An important goal 
of this research trajectory is to develop plants entirely dependent upon 
appljcation of a specific proprietary rhemical. 
Plant genetic engineering offers a number of possible research goals 
ranging from producing plants engineered so as to not require herbicides 
because they are very competitive with weeds to those engineered to requjre 
herbicides. The first research goal obviously is not as interesting to an 
herbicide manufacturer as the second. Thus, Monsanto, the producer of a $500 
million per year in sales molecule called Roundup, and Lasso, an over $100 
million per year herbicide, is investing tremendous sums to investigate plant 
herbicide-resistance. If the gene for Roundup-resistance can be successfully 
cloned in a plant (this was accomplished by Calgene last year) (Comai et al. 
1981), then greater quantities of Roundup can be used on crops. In a more 
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general way herbicide-resistance is becoming a research goal for increasing 
numbers of plant scientists. 
Another important area of research in which bjoterhnology cou]d assist is 
the development ot economically efficient hybrid strains of rice ~nd wheat. 
The reason the farmer adopts the hybrid seed is that successful hybridization 
can provide twenty or more percent yield increases. The quality nf hybrids so 
attractive to industry is that the harvested grain cannot be replanted with 
the same results. Thus, the farmer must return annually for new ~eed, bPcause 
the hybrid's progeny are not uniform, thereby guar~nteeing an annual market. 
This is not to sav that hybridization is bad. In a situation in whirh thP 
farmer could be guaranteed access to low cost seed supplies, hybridization 
could prov1de increased yield, a desirable outcome. The problem is more 
complicated if the farmers are located in ~ TWC and the seed company is based 
in a developed country, because a dependency on imported seeds might be 
developed.(9) 
Commercial hybridization has for the last thirty years been ronfined to 
corn and sorghum. Recent breakthroughs in rice through the discovery of 
cytoplasmic sterility and in wheat by the development of pollen sterilants arP 
permitting the development of hybrids in those crops. The hybrid rice is 
especially important because within five years the Internatjonal Rice 
Research Institute will be releasing varieties suitable for cultivation upon 
the ten million hectares now cultivating IR36 (Kenney 1984). The People's 
Republic of China already has 6 million hectares growing hybrid rice 
(Swaminathan 1982:971). It is not too early to explore the types ot infra-
structure that will be necessary to ensure the prompt regular delivery of the 
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nPPrlPd hybrid sPed to thP f~rmer--tardinPss in delivery would be disastrous as 
thP tarmer will be unabll"' to replant rPtained seed. 
IRRI is not the only organization exploring the potentials for hybrid 
rire. Ocridenta] Petroleum, through its Ring Around Seeds, and Cargill Grain 
Company have purchased rights to sell Chinese rice varietiPs ln LDCs (Kenney 
1984). lf the hybrid rice market proves to be commercially lucrative, then it 
is likely that inrreased pressure will be applied to IRRI to remove itself 
from hybrid rirE> production and tree di::~tribution of improved germ plasm. 
This prE-ssure could be exerted through the funding that IRRI receives from 
developed countries.(l0) 
The impacts of tissue culture research upon plant breeding will be 
enormous. Scientists may be able to develop HYVs that are tolerant of 
environmental adversity such as high soil aluminum content, salinity or 
waterlogging, to name only a few. This could have the impact of transforming 
formerly marginal agricultural lands into productive valuable land. These 
lands, however, are usually not without agriculturalists. It is likely that 
similar events will occur due to these new HYVs as occurred in the previous 
Green Revolution whereby entire groups of farmers and landless laborers were 
enrlosed from the land because of the new seeds increased land values (Pearse 
1980). 
Bjotechnology provides not only possibilities of crossing sexually 
incompatible plants, but also of speeding up the breeding process. This is 
important because it currently takes ten to fifteen years to provide a new 
vari@ty to the farmer. Th~ use of tissue culture can spePd the reproduction 
cycle and reduce response times for the creation of new varieties. This is 
important because pests are constantly mutating against field crops and 
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scientists must constantly develop new varieties. Thus, tissue culturP can 
become an important addition to the traditional tools of plant breeders. 
The Green Revolution was specifically directed towards food grains. but 
the biorevolution will also affect agroexport crops. Tissue culture can be 
used to clone plants such as trees that require long maturity periods making 
it possible to vegetatively propagate and reproduce e]ite trees in large 
numbers. These techniques are already being used for palms, agave, bamboo, 
orchids, coffee, sugarcane, banana, cacao, and plantains, among others. In 
many cases vegetative propagation technology is not overly sophisticated and 
can be undertaken by a relatively well-equipped laboratory in a TWC. 
The application of these crop improvement techniques will be very 
important in assuring that TWC export crops are not displaced by substitutes 
produced in developed countries. As happened in the case of high fructose 
corn syrup based ttpon immobilized enzyme technology successfully competing 
with sugar in developed country markets.(ll) The response of sugar exporting 
countries must be to decrease their production costs not only by decreasing 
costs of refining, but also by developing better canP varieties. Biotechnology 
offers a tool in this competition, as immobilized enzymes were the tool that 
the corn wet millers used to enter the sweetener industry. 
As indicated earlier the new biotechnologies offer great potentiRl for 
increasing the productivity of nearly any crop. However, the large potential 
increases in productivity carry with them social consequences which are not 
predictable in the abstract. If redistributive programs are not ]mplemented 
simultaneously with the application of biotechnology the poorest will be the 
victims rather than the beneficiaries of biotechnology. The role of the MNCs 
in delivering the products of biotechnology may also pose problems for 
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countries trying to develop national bioterhnology programs. Very obviously, 
the next twenty years will be ones of tremendous technical change in agri-
culture and agroforestry production systems. 
Genetic Erosion 
The last ten years have led to an increased awareness among agricultural 
scientists of the erosion of the world's genetic resources (Jain 1982, Wilkes 
1983}. Genetic resources refer to the genetic variability that different 
plant varieties have encoded in their DNA. For example, the many varieties of 
corn have different qualities: yield, stature, pest resistance, moisture 
tolerance, etc. Those djfferences reflect differing capabilities of res-
ponding to environmental variation. The plant breeder used these qualities 
(genes) as raw material for the breeding process. Obviously, the larger the 
pool of varieties available the greater the inventory of traits available for 
breeders. When a greater number of varieties with different characteristics 
are planted, not only do you have more information, but also the total crop 
planted has greater resilience. As an example, if there is a drought, at 
least the drought-resistant varieties survive. The same is true regarding 
pest infestations. Conversely, the monoculture of a single variety creates a 
more fragile system in that if this variety succumbs to an environmental tort 
each of the genetically identical plants are affected posing the possibility 
of an epidemic. 
The major centers of plant genetic diversity are located in the TW. Thus, 
TWCs are the source of genetic materials for the food we produce, export, and 
consume. The modernization of the TW agriculture is creating a situation in 
which single genetically uniform varieties are being sown over large acreages 
and displacing traditional varieties. The response to the problem of genetic 
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erosion has been the collection and storage of traditional seed materials in 
germplasm repositories. However, in the last few years the preservation 
process has become politicized because TWCs are charging that these genetic 
resources are being collected, used in plant breeding in DCs, and the products 
are then resold to TWCs. TWCs are demanding if there is to be a free flow of 
germplasm (seeds) to developed countries, then the finished seeds should also 
flow freely (Mooney 1983)! The TWCs' position is that the current system is 
merely another method of exploiting the resources in the TW for the benefit of 
the MNCs. The response of the DCs has been that these genetic resources are 
the common heritage of all mankind. 
The entire debate regarding genetic erosion has become increasingly 
bitter because the pending biorevolution has increased secrecy and th~ 
potential value of genetic information (Walsh 1984:148). Many TWCs are 
beginning to forbid germplasrn collection within the nation, even as other 
countries such as Japan and China hasten to construct new and larger gerrnplasm 
repositories. As for genetic erosion. it appears that this process is largely 
irrevocable. The final outcome of current trends could be that the TWCs 
currently possessing in situ gerrnplasm resources will find that thPir genetic 
resources have disappeared and are only available from developed country 
storage facilities. Thus, those formerly genetically rich will have been 
transformed into those genetically poor--the wheel turns full circle. 
Animal Husbandry 
The biorevolution will not be confined to plants and, in fact, will 
probably initially have as great or greater impact on animal husbandry. There 
are three distinct areas in which biotechnology will impact animal produrtion: 
the use of bacterially-produced hormones, new vaccines, and the new reproduc-
tive t~~hnologies. These techniques are, in principle, applicable to any 
animal, but the animals rereiving the bulk of the research are cows, swine, 
anrl chicke-ns. Animals important to TWC agricultural production such as 
camels, water buffalos, and llamas are receiving far less attention than even 
dogs or cats. This is because the owners of these pets hav~ greater effective 
demand than the millions dependent on water buffalos or camels--and these 
technologies are being developed by for profit companies. 
New techniques to control animal reproduction are already on the market 
in DCs. The animal having the largest market potential and receiving the 
greatest research attention is the cow. Bovine artificial insemination has 
been available for many years, but in the last ten years scientists have 
developed techniques for nonsurgically transferring embryos from one cow to 
anothPr. This is coupled the use of hormonal preparations to induce the cow 
to superovulate, i.e., to simultaneously release up to twenty ova from its 
ovaries, whereupon the cow is artificially inseminated. After six days the 
fertilized embryos arP removed and transplanted into "surrogate" mothers 
using nonsurgical embryo transfer techniques which already routinized and 
performed by farmers in developed countries. These techniques make it 
possible to greatly increase the number of elite dairy cows that can be 
reproduced. 
Embryo transfer is leading to other services. Until recently, the 
embryos had to be transplanted into the surrogate mother within one or two 
days, but freezing techniques have improved sufficiently to provide a thirty 
percent survival rate and is becoming commercially viable. A U.S. company, 
Genetic Engineering, Inc., has developed a technique for sexing embryos before 
implantation (Genetic Engineering, Inc. 1982). This allows the dairy farmer 
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to select females and the cattlemen to select males saving the cost of 
bringing an unwanted embryo to term. It is also possible to split or twin 
fertilized ova (at this point up to sixteen identical clones can be produced). 
Because of the freezing techniques it is possible to raise an adult cow, 
measure its milk production or weight gain, and if production is satisfactory, 
the elite cow's identical twins can be thawed out and implanted in a surrogate 
mother. 
For TWCs these new animal reproduction techniques offer increased 
flexibility and opportunities. For example, it is possible to move hundreds 
of embryos from elite parents in a suitcase sized freezer to any location. The 
embryos are not subject to quarantine and, of course, are not as large, 
unwieldy, or expensive to transport as one full-grown cow. As an added bonus, 
the surrogate mother provides environmental immunities to the young calf, thus 
drastically reducing mortality rates for cattle imports. The speed with which 
a Third World cattle herd could be upgraded is greatly increased and purchases 
of elite germplasm are inexpensive in comparison to adult cows.(l2) 
Another major obstacle to TW animal husbandry has been the number and 
seriousness of animal diseases. Biotechnology provides numerous opportunities 
to attack animal diseases (Table 9 lists disease vaccines under development 
and some market information). Obviously vaccines could provide important 
economic benefits. But, as in the case of plant biotechnology, the animal 
diseases first tackled will be those that are most profitable--not those 
endemic to the TW. The reason that animal vaccines are so early on the market 
iR a function of two variables. The first variable is that biot~chnology 
expertise was developed in medical schools and biology departments that were 
doing research on human vaccines. Though the research concerned human 
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vaccinP.s, much of the know]Pdge easily adapted to animals. The second 
variable is that animal health products, though similar to human health 
products technically, require a far shorter testing period and receive rapid 
market approvals. Therefore, many companies have emphasized animal health 
products. 
For TWCs the single most commercially important vaccine is the foot and 
mouth disease (FMD) vaccine being developed separately by Genentech and 
Molec\tlar Genetics <Genentech 1982; Molecular Genetics 1982). FMD is a 
virulent and economically dPvastating bacterial disease that infects cloven-
heaved animals. The costs of FMD eradication efforts are huge. The elimina-
tion of an FMD outbreak in England in 1967-68 cost in excess of $200 million 
and a similar Canadian outbreak in 1952 was estimated to have cost $1 billion 
(Blackwell 1980:1019). The high costs of controlling FMD oblige uninfected 
countries to embargo meat shipments from infected regions such as Argentina, 
Brazil and most of Africa to the USA and Japan. 
The market for a safe, effective, and easy-to-handle FMD vaccine is huge. 
For example, Argentina imports 200,000,000 doses per year of the attenuated 
virus vaccine from Burroughs-Wellcome of the United Kingdom (Allende 1984). 
The vaccine must be administered every three months and, in certain cases, has 
actually caused FMD outbreaks (Blackwell 1980). The gen~tically engineered 
vaccine cannot cause disease outbreaks and should be more effective. A number 
of companies in addition to Genentech, Molecular Genetics and Burroughs-
Wellcome are pursuing a FMD vaccine, though none has yet developed an entirely 
effective one. 
The impact of a totally effective FMD vaccine could be an enormous 
increase in meat exports by TWCs to the developed countries because the 
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barriers to meat entry into FMD-free countries could be dropped. The 
increased exports could easily increase the value of grazing land and perhaps 
cause a shift from food cultivation to animal grazing. Increased meat exports 
for the tables of the middle-class in the U.S., Europe, and Japan at the 
expense of the TW poor certainly is a possibility and, perhaps, even a 
likelihood. Each of the vaccines listed in Table 9 offers the potential of 
increasing efficiency and productivity in animal husbandry and just as surely 
offers the possibility of shifting relative factor prices against poor farmers 
and consumers in TWCs, perhaps increasing relative or even absolute poverty. 
Genetic engineering has made it possible to produce bovine, porcine, and 
chicken growth hormones and bovine interferon. Bovine growth hormone has been 
shown to increase a cow's milk productivity by between 10-20 percent (Peel et 
al. 1981). Similar results have been achieved with chicken growth hormone in 
speeding the growth of broilers (Boone et al. 1983). However, the actual 
utilization of these growth hormones is blocked by the lack of an adequate 
delivery system--the hormones are metabolized in the digestive tract when 
taken orally. Bovine interferon is being tested for prevention of shipping 
fever, a disease that results in severe weight loss in up to 30 percent of 
cattle housed in feed lots (Wall Street Journal 1983:36). The increasing 
number of animal agriculture inputs will make animal production more efficient 
for those able to afford these inputs. The range of impacts of biotechnology 
on animal husbandry is truly profound. The changes will provide opportun-
ities for drastically increasing productivity and international trade. 
Whether this will improve the living standards of peasants and TW consumers 
depends upon the ~teps taken to insure distributive equity. 
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Industrial Plant Tissu~ Culture (PTC) 
The increasing skills of manipulating plant mater~als in tissue culture 
has made it possible to select and reproduce plant cells that produce valuable 
chemicals in vitro.<l3) Rapid advances in PTC have made what was formerly 
only a scientific tool into a commercial innovation. There are already two 
PTC products available to consumers: shikonin, produced by Mitsui Petro-
chemical Co. (Tanaka 1983a) and berberine, produced by a German company (Zenk 
1984). Increasing numbers of DC research laboratories. both public and 
corporate, are initiating PTC research and many high value plant-derived 
products are vulnerable to displacement. The process of substituting indus-
trially produced inputs for agricultural commodities is not new, e.g., the 
displacement of indigo with aniline dyes. PTC will continue and exacerbate 
this historical trend. TW agricultural planners must understand the reasons 
for product displacement so as to be better prepared to counteract the 
process. 
There are a plethora of plant products cultivated for pharmaceuticals, 
dyes, flavorings, and other specialized high value uses. Typically, these 
plants can only be cultivated in certain specific geographical and environ-
mental regions. Conversely, locales cultivating the plants may be very 
dependent upon the income generated from sales of the products. PTC will 
significantly impact these economies as DC importers increasingly will be able 
to manufacture these products in fermentation plants (Table 10 presents a list 
of products currently undergoing PTC experimentation). 
PTC has many advantages when compared to conventional agricultural 
production. The production of plant chemicals in an industrial process allows 
more complete quality control and product supply would no longer be subject to 
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the vagaries of weather, transportation, season or politics--the production 
process is more controlled and predictable. Difficulties with farming systems 
such as the ability to recruit more farmers and secure suitable land are 
circumvented. Fermenter-based production processes are more flexible thus, if 
larger product quantities are needed the company need only add another 
fermenter. Conversely, if a product oversupply exists the fermenter can 
either be mothballed or transferred to manufacturing other products--a very 
difficult and expensive switch for a farming system. For many plant products 
sophisticated, expensive separation systems to extract the desired chemicals 
from the economically useless parts of the plant are required. For example, 
the active ingredients of the opium poppy must be extracted from cell mass of 
the poppy buds at considerable expense, whereas with PTC only cells producing 
the active ingredients are cultured. A PTC factory can work continuously 
thereby eliminating the need for sizing the plant for peakload. Whereas the 
machines for conventional agricultural production are in use only during the 
harvest season. 
The primary disadvantage of PTC remains the high costs of production. The 
point at which PTC becomes a viable alternative to agriculture has been 
estimated to be at approximately $600 per kilogram (Leonard 1983; Tudge 1984). 
However, it should be noted that increasing research and production exp~rience 
will allow these production costs to be brought down significantly. The lack 
of experience in handling large-scale fermentation operations is also a 
handicap to industrial production, but this is being overcome by scale-up 
research and "hands on" experience. 
As indicated earlier, the impact of PTC wi.ll not he immediatE> hut 
cumulative as the TW producers experience product market stagnation and 
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evPntnal erosion. A vivid example of this was the destruction of the Indian 
indigo industry in the pre-World War I period by the German synthetic. indigo 
dye industry built by companies such as BASF and Hoechst. When the synthetic 
was first marketed in 1897 there were 574,000 hectares under indigo cultiva-
tion in India, by 1911 the land under cultivation had declined to 86,600 
hectares, and by 1920 the jndustry had nearly disappeared (Martin-Leake 
1975:368). The Indian regions formerly most dependent on indigo cultivation 
still have not entirely recovered from the effects of thi~ technological 
innovation. Similar displacements occurred in the post-war period as nylon 
rope made by Dupont drove jute (Bangladesh) and hennequin (Yucatan, Mexico) 
from the world rope market. Another well documented case of displacement by 
scientific innovation is the demise of the Mexican steroid industry in the 
1970s (Gereffi 1978). PTC is so important because it can be applied to any 
plant, whereas synthetic techniques are limited by the technical difficulty of 
synthesizing many plant products. 
Many products that could be displaced by PTC are the monopoly or near-
monopoly of a select few countries. These countries must prepare for the 
dissolution of these monopolies by pricing products in such a way as to either 
extract maximum profits to be invested in other industries or in rationalizing 
production so as to be more competitive. To merely remain idle or blissfully 
unaware of the biotechnology's threats is not a viable alternative. The result 
of inaction will be the destruction of an export industry with no plans 
prepared to alleviate the plight of the farmers and workers dependent upon 
that industry. 
30 
Genetic Engineering and Industrially Produced Agricultural Products 
This section discusses a heterogeneous number of other biotechnology 
applications which will profoundly impact agricultural systems. The majority 
of these techniques are targeted for DC agriculture. Nonetheless, areas such 
as improved nitrogen fixation are also receiving attention in TW research 
institutes. Other research such as single cell protein production is confined 
to DCs and their MNCs. For purposes of clarity the following discussion has 
been divided between industrial processes using genetically engineered 
microorganisms and genetically engineered inputs to agriculture such as 
microorganisms and microbial pesticides. 
Industrial Microbiology 
The engineering of a microorganism's metabolic pathways makes it possible 
to efficiently convert low value feedstocks into higher value products such as 
amino acids, proteins, and specialty chemicals. In certain cases the products 
of these altered microorganisms will efficiently compete with agricultural 
production. Much research money is being invested in developing micro-
organisms capable of transforming agricultural wastes consisting largely of 
cellulose and lignin into higher value products. However, researchers have 
yet to do it economically. Table 9 indicates there are a number of applica-
tions currently being investigated and will undoubtedly be many more as 
increasing numbers of MNC food processing giants enter the industry. 
The microbial production of SCP has received much attention from large 
petroleum and petrochemical companies due to protein's relatively high value. 
For two years, Imperial Chemical Industries has produced SCP animal feed but 
the facility has yet to become competitive with soybean protein. The ICI 
process feeds yeast on methanol and requires an approximately equivalent 
)I 
amount of fosstl fu~l ~nergy as soyb~an production, whilP ustng only one-t~nth 
thP labor, however capital investment is very high (Yanchinski 1981). If 
increasingly efficient yeast strains and process engineering are developed the 
SCP process may become cost-effective. For oil exporting countries the 
production of SCP may make economic sense even earlier because of the ''free" 
natural gas. The successful entry of OPEC countries into the world protein 
markets would certainly disrupt the agricultural economies of countries that 
export cattle protein feeds (soybean cake- U.S., Argentina, and Brazil and 
peanut cake- Senegal and other West African countries). However, SCP has not 
yet had even a modest economic success. 
On the other hand, the fermentation of the amino acid, lysine as a cattle 
feed supplement has grown immensely. The two major world producers, Ajinomoto 
and Kyowa Hakko, have recently constructed new amino acid production facili-
ties in the U.S. and both are actively using genetic engineering to develop 
more efficient microorganisms (Yugari 1984; Samejima 1984). Lysine is an 
example of the contradictory impacts biotechnology could have. Genetic 
engineering of microorganisms could make lysine production less expensive, but 
genetic engineering could develop corn plants that produce sufficient lysine 
so as to eliminate the need to add lysine to cattle feed. Research, invest-
ment, and success in either option will impact the structure of agriculture 
differently. 
Genetically improved microorganisms could provide Brazil's ethanol 
program with much more efficient production processes. This may be a mixed 
blessing because the current ethanol project has already contributed to a 
redistribution of income and land away from peasants and workers and toward 
the sugar barons (Vellutini 1984). Therefore, making the project more 
efficient may only encourage the spread of sugarcane farming compounding rural 
poverty. French researchers are also undertaking to develop microbial 
techniques to transform inexpensive oils such as corn oil into more valuable 
oils such as that of cocoa (Canteley and Sargeant 1981:331). In this case 
many LDC plant oil exporters could be seriously affected by competition from 
DC companies in the international food oils market. Examples of other 
techniques under development include one Japanese company's plan to develop 
bioreactors on board vegetable oil tankers (Tanaka 1983b). These tankers 
would process the food oil even while enroute to Japan decreasing the neces-
sity of investments in food oil processing plants in DCs and shortening 
product turnover time. 
Microbes and Microbial Pesticides as Agricultural Inputs 
The use of microbes in agriculture has received increased attention due 
to increased emphasis on the use of more environmentally benign agricultural 
inputs. The variety of beneficial agricultural microbes ranges from insecti-
cide and fungicide producing to nitrogen fixing and frost preventive bacteria. 
Within this broad range there are many applications that could quickly be 
adapted to TW conditions and in many cases would require very few imports. 
Perhaps the best known insecticidal microbe is Bacillus thuringie~is, a 
virulent antagonist of many insects. In combination with integrated pest 
management techniques the use of microbial insecticides can significantly 
reduce pesticide costs (Orrego 1981:67-75). Already UNDP/FAO is funding 
projects to use ~~~il~~~ to control olive pests in Greece and alfalfa pests in 
Argentina (Orrego 1981:68). Similarly, the fungus, Jri_choderma _ _b~_r-~f~!:l~!!l· is 
being used to control other fungi (Orrego 1981:77). These microbial pesti-
cides are being sold in the DCs by companies such as lfpjohn. However, in many 
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cases, crude but effective methods can be developed to produce these pesti-
cides in Third World environments at very low cost. 
Another important agricultural role for microbes is in the fixing of 
nitrogen from the atmosphere. This can occur in three ways: through bacteria 
living in symbiosis with legumes, free-living microbes in the soil, or blue 
green algae. The most radical claims of certain biotechnologists has been 
that they will engineer grain plants able to fix their own nitrogen. The 
technical difficulties of genetically engineering symbiotic nitrogen fixation 
are enormous, e.g., there are at least seventeen genes involved with symbiotic 
nitrogen fixation. Questions have also been raised as to whether yield losses 
due to nitrogen fixation energy demands would be economically prohibitive 
(Anderson 1980:35). A corollary question is whether photosynthesis in plants 
can be made efficient enough to compensate for the energy used in nitrogen 
fixation (Anderson 1980:38). In fact, engineering corn to fix nitrogen could 
lead to yields at least 10 percent lower than those currently achieved 
(Ch~mi~~~eek 1980:28). Plants and bacteria engineered to symbiotically 
produce nitrogen economically is probably far in the future and even geneti-
cally "improved'' free living soil nitrogen fixers probably may not be success-
ful in competing with the naturally occurring soil bacteria or natural 
gas-derived fertilizer. 
The most promising research area for reducing fertiljzer consumption in 
the next ten years is the development of farming systems using blue-green 
algae and Azolla (Jagannathan et al. 1978:20). The Azolla ferns provide 
energy and living sites for the algae and the algae produce nitrates which the 
Azolla absorbs. Rice paddies fertilized with composted nitrogen-rich Azolla 
report yield increases of 12-14 percent higher than yields in control rice 
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plots. IRRI has had considerable success in spreading the usage of Azolla to 
countries in noncommunist Asia--Azolla was first used in North Vietnam and 
China. Nevertheless, though research is forging ahead and a number of 
research institutions are committing research funds to biological nitrogen 
fixation, success in fields other than Azolla usage is probably relatively 
remote. 
The reason for great emphasis on biological nitrogen fixation research in 
TW environments is obvious--foreign exchange savings. Whether, with the 
exception of the Azolla research, BNF is a well placed investment is certainly 
open to question. For example, J. Eugene Fox (1984), president of ARCO Plant 
Research Institute, believes any viable applications of BNF are at least five 
to ten years away. The problems with BNF include: 1) normal soil conditions 
may not provide free-living nitrogen fixers with the required energy sources, 
2) the nitrogen that is produced will not be directly absorbed by the plant, 
thereby rendering the process relatively inefficient, and 3) ammonia may be 
overproduced rendering the soil acidic. BNF, at first, appears to be an ideal 
strategy--fertilizer can be produced by farmers at very low cost. However, if 
the BNF research does not successfully come to fruition, TWCs will have 
squandered much of their research resources on a gamble that has already been 
abandoned after major investments by companies such as Allied Corporation. 
Summation 
This section has briefly surveyed the myriad possibilities that the new 
biotechnologies are providing for agriculture. In a number of specific 
instances the- political economi.c implications of the commercial success of 
these developments were highlighted. It is obvious is that each of these 
techniques has contradictory implications. The benefits of biotechnical 
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change will be captured by those social groups most able to shape research 
agPnda and demand their share of the benefits. If the poor and oppressed 
cannot make their desires heard, they will most certainly not reap the 
benefits of this new productive force. This is especially true in a global 
economy in which biotechnology is increasingly becoming a science controlled 
by a corporate research agenda based upon profit maximization and not by the 
needs of the TW poor. 
TWCs must become actively involved in biotechnology research. The 
biorevolution will involve all areas of agriculture regardless of whether a 
single country opts to invest in biotechnology. The uniqueness of biotech-
nology is that there are many levels of entry and economies of scale are not 
entirely operative. Useful products can be generated at very low capital 
intensity, this is a knowledge-intensive industry and its tools can be 
directed at unique national problems. However, it must be recognized that 
biotechnology is not a panacea nor will research yield rewards overnight. 
Third World Countries' Responses to Biorevolution 
The biorevolution offers many opportunities to TWCs to secure real 
economic gains. However, securing these gains will require more than simply 
lavishing money and equipment on scientists and hoping for success. 
Fundamental to long-term success is a program of elementary and secondary 
education dedicated to bringing hands-on scientific experience to a nation's 
students. TWCs will be required to inventory their national resources and 
prepare a long-term biotechnology plan complete with targets and realistic 
goals. Applied research must be directed in such a way as to maximize its 
relevance to the needs of the country. This emphasis on applied research must 
be reinforced by analysis of what is technically and economically feasible. 
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There is no single correct strategy. For example, India with its large 
research budget and pool of trained manpower will necessarily have a different 
approach from that of, say, Zimbabwe. Yet, even the smallest and poorest 
countries can participate in the biorevolution through regional and inter-
national networks. Participation need not be in thA most sophisticated basic 
research, but rather should match national skills and research expertise with 
problems that can be tackled. The greatest mistake would be to attempt to 
mimic the research agendas of the DCs. 
Biotechnology Institution Building 
The difficulty of establishing a biotechnology industry in TWCs is 
obvious. It is useful to briefly list some obstacles to establishing an 
effective national bioindustry capable of providing products to enhance 
development. The first principle is that the biotechnology industry is more 
knowledge-intensive than capital-intensive, but biotechnology is not a free 
good. As mentioned earlier, a U.S.-style "high tech" biotechnology company 
would require at least well-trained 25 Ph.D.s and approximately $10-12 million 
in initial investment capital. The scale-up of R&D to the industrial level 
wottld cost much more. Yet, even Eli Lilly's rDNA insulin plants cost only $40 
million each (Kramer 1982:1). A monoclonal antibody endeavor would probably 
cost from $3.5 to 4 million over three years (Treble 1982). In fact, few of 
the biotechnology start-up companies in the U.S. have invested more than $200 
million dollars since their founding so the costs are still relatively low. 
DC-level tissue culture laboratories for plant improvement capable of having a 
number of ongoing projects can be established for $100,000 to $300,000 (Zapata 
1984). 
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These costs may seem high, yet when rompared to the costs of building 
luxury car assembly plants or importation of weapons, the costs of scientific 
research are not unreasonable. The most sophisticated equipment need not be 
purchased immediately, but rather a well-planned purchasing schedule could be 
developed to bring new equipment into service gradually. This allows the 
equipment to be absorbed and brought into service in a deliberate, rational 
manner.<l4) This also would encourage scientists to become resourceful and 
innovative in coping with shortages. 
The greatest obstacle to LDC involvement in biotechnology is not lack of 
investment capital, but rather a lack of trained personnel. The decades of 
"brain drain" have resulted in the emigration of many Third World scien-
tists.(l5) This drain has been accompanied by lack of emphasis upon and 
opportunjties in the TW to do basic or applied biological research. Many of 
the TWCs' most able molecular and cell biologists, virologists, and immunolo-
gists, after post-graduate training remained in the- DCs. Another complication 
is the fact that many TWC scientists have financial linkages to DC companies. 
The lack of trained scientists is not the only personnel deficiency 
experienced in many TWCs. There is also a shortage of trained technicians 
capable of maintaining and repairing sophisticated scientific machinery. 
Technicians are a vital component not only for laboratory work, but also for 
the process of moving to full-scale production. Technicians as a group are 
often neglected because of their comparatively low prestige and pay, yet they 
are absolutely vital to a successful biotechnology industry. Thus far, only a 
few countries, e.g., Mexico, Brazil, India, Cuba, and China have the critical 
mass of scientists and technicians necessary to launch a viable large-scale 
biotechnology effort. 
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There are oth~r LDC disadvantag~s that can b~ characterized as infra-
structural in character. David Baltimore (1982), Nobel Laureate, professor at 
MIT, and part owner of Collaborative R~search, has pointed out the critical 
need that biotechnology R&D facilities have for steady, dependable public 
utilities such as electricity and water. For example, a prolonged electricity 
outage could result in the loss of months of work. Transportation services 
are also important, because certain enzymes are very unstable and must be 
delivered in a frozen state within 48 hours of shipping or they deteriorate 
and become useless <Baltimore 1982:34). Biotechnology laboratories also have 
sophisticated imported machinery that is difficult to service and might 
experience long downtimes while waiting for repair or service originating in 
d~veloped countries. The entire problem of inadequate infrastructural 
development may be even further reinforced during periods of economic or 
political uncertainty when the immigration and customs service can almost 
completely break down. 
Another blockage in creating an effective biotechnology industry may be 
characterized as a lack of political will and resolve. An investment in 
biotechnology is not a one-time investment, but rath~r requires constant and 
growing investment as projects come to fruition. The prospects for immediate 
riches such as are realized in the U.S. when the stock is sold to the public 
are not possible in TWCs. False expectations of the ease of success sometimes 
fostered by the scientists themselves will rebound to the detriment of 
creating a viable biotechnology industry. 
The final important obstacle to success in biotechnology is the choice of 
appropriate research targets. The usual scenario is the TW government to 
respond to a perceived need for a biotechnology industry by requestin~ 
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univPrsity scientists to formulate a biotechnology program. This program is 
then funded by the govPrnment with little further analysis. The professors 
then allorate the money among themselves, return to their laboratories, and 
continue their ongoing research. Years pass, very little emerges from the 
laboratories, and government interest and ftmding wanes. Eventually, the 
country finds that it is hopelessly behind in the technology and large sums 
have been used in a manner that will provide no return. <~ly after appro-
priate business-like analysis of the financial costs and benefits should a 
project be financed. The criteria for financing must be based on reasonable 
opportunities for economically viable success, simply accepting the claims of 
scientists is not sufficient criteria for fund allocation. 
National Biotechnology Programs 
A number of countries have launched national biotechnology programs 
including: Cuba, China, Brazil, Argentina, Thailand, India, Algeria, Korea, 
the Philippines, and many more are making investments in this area. This 
section will examine the undertakings of two very different countries, India 
and Cuba, outlining the strengths and weaknesses of their respective efforts. 
The programs of other countries are also briefly discussed. Linkages between 
institutions in the DCs and TWCs are described and their benefits and costs 
are explored. It is argued that biotechnology is a broad field in which the 
resourcefulness and flexibility of TW scientists will provide ample oppor-
tunities to develop research programs uniquely suited to particular national 
needs. 
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India 
India will undoubtedly have some success in its biotechnology effort due 
to its large industrial base and extensive cadre of educated scientists. The 
Indian biotechnology effort received top-level support from the late Prime 
Minister, Indira Gandhi (1982), and is able to tap the expertise of top Indian 
emigre scientists.(16) However, an important (and unpredictable) variable 
affecting the success of the Indian effort will be the degree of commitment 
that the important Indian private sector will assign to biotechnology.(17) 
With the support that biotechnology is receiving at the political level India 
will develop a viable program. 
The late Indira Gandhi established a National Biotechnology Board (NBB) 
to organize India's national effort. The NBB (1983) has developed its "Long 
Term Plan in Biotechnology for Indiau that formulates specific proposals meant 
to ensure India's participation in biotechnology. The NBB will encourage and 
facilitate interdisciplinary research and build the infrastructure necessary 
to support research. For example, the Indian government has undertaken to 
import and supply necessary enzymes and biochemicals and is setting· up 
production facilities for the most important of these (NBB 1983:30). The 
government is also giving high priority to the import of needed equipment. In 
the personnel area, the plan calls for the training of 50-100 ''biotechnolo-
gists" annually. On the other hand, no mention is made of training tE-ch-
nicians to repair equipment and assist in other activities crucial to labor-
atory success. 
India is rich enough in universities and research institutes that it can 
do any but the most state-of-the-art research. India's large number of 
researchers, stable foreign exchange situation, and excellent universities 
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pt'nnit infrastructure building which most countries could not afford or 
support. The Indian gov~rnment is developing a large-scale program that 
addresses all aspects of creating a biotechnology industry. The success of 
the program will significantly contribute to Indian agricultural and indus-
trial productivity. Another major contribution to the Indian biotechnology 
effort was the decision to locate one center of the International Center for 
Genetic Engineering and Biotechnology (ICGEB) in India. 
Cuba 
In contrast to India, Cuba has a much smaller industrial and research 
base. However, this has not precluded Cuba from making an important invest-
ment in biotechnology. The Cuban R&D goals are strongly influenced by the 
concrete development and needs of the economy including: the commitment by 
the Cuban state to improve medical care, the importance of agriculture (sugar 
and tobacco) to the economy, the political commitment to raising animal 
protein consumption in Cuban diets, the desire to be an exporter of biomedical 
products, and strong research capabilities in the agricultural and medical 
sciences. However, Cuba does not aim to be a scientific leader in world 
biotechnology. Rather, the Cubans wish to take advantage of the results of 
research conducted overseas by remaining somewhat behind the cutting edge of 
DC science, yet in a position to exploit commercial aspects of scientific 
devt'lopments. 
Cuba launched a biomedical genetic engineering laboratory with its first 
project being to produce interferon using the Cantel process. Laboratories 
are also examining the possibility of using rDNA to produce alpha interferon. 
In pursuit of the interferon project, Cuba has held an international inter-
feron conference in Havana and launched a journal entitled Interferon e 
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Biotecnologia. The reasons for undertaking the interferon project are: 1) to 
be used as a model system to learn rDNA techniques; 2) for its immediate 
medicinal usage (Ubell 1983:344); 3) the personal interest that Fidel Castro 
has in the project (Anonymous source 1984); and 4) as a demonstration of 
Cuba's technical expertise. Other major projects underway are the use of 
tissue culture to improve sugarcane and animal vacc.ine production. Cuba has 
also had success in bovine embryo transfer (Paiges 1984). Finally, Cuban 
scientists claim to have successfully extracted lysine from yeast and already 
introduced the method into Cuban industry (Ubell 1983:746). 
Cuba is launching an expensive product-focused drive to introduce 
biotechnology into the economy. Eric Holtzman, a Columbia University pro-
fessor of cell biology, states: "They've aimed very carefully to develop a 
scientific enterprise which is not intended to ape world class research" 
(quoted in Ubell 1982:745). The Cubans have chosen targets that can benefit 
the ordinary Cuban. The reason for this targeting according to Cuban scien-
tists is that relative poverty and immediate problems prevent investments 
having no medium-term payoff. This, of course, implies that the Cubans will 
remain consumers rather than producers of basic research. 
Under the very adverse situation which limits Cuban access to U.S. 
universities and laboratories, Cubans have been very resourceful in securing 
access to information. Cuban scientists have trained in Europe and the USSR. 
Cuba also actively encourages foreign scientists to conduct scholarly visits, 
e.g. Marc Van Montagu, one of the world's foremost plant scientists, recently 
visited Cuba (Osa 1984:4). T~chnicians are sent for training to Japan and 
elsewhere to learn to repair and maintain purchased equipment (Ubell 1983: 
344). Though the Cubans are now producing some ~quipment and enzymes, th~ 
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morP sophisticated items are still imported. To increasp arcess to foreign 
information sources the ~1bans are to hP linkPd to the Soviet on-line rlRta 
retrieval network lUbell 1Y83). 
The Cubans, though having a much smaller population and industrial base 
than India, are making a determined effort to participate in the biorevol-
ution. As part of this strategy, they are taking advantage of linkages and 
services offered by international and regional organizations such as the 
fledgling Latin American Biotechnology Network. The success Cuba has had in 
building a significant advanced biotechnology research establishment clearly 
demonstrates that political commitment and desire can overcome many obstacles. 
There are even simpler efforts than those discussed thus far that can be 
undertaken such as clonal propagation of certain agriculturally important 
species. For example, in Vietnam family-size potato tissue culture facilities 
have been established. These laboratories reproduce and distribute to farmers 
elite potato varieties such as those developed by the International Potato 
Center (CIP) in Peru. A single facility can produce 100,000 clones per month, 
rapidly speeding the diffusion of new varieties (Uyen 1984:5). The Vietnamese 
example illustrates that biotechnology can be adapted to meet many different 
goals. Other countries as varied as Nicaragua and the Philippines are 
developing low-cost techniques for microbial pesticide production. In many 
ways biotechnology success is only limited by the dedication and imagination 
of TW scientists. 
Linka~~s Between Th!!d World Institutions 
and Biotechnology Startup~ 
The traditional routes for TW institutions, private and public, to secure 
technology has been either to contract with large MNCs to provide licenses, 
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sE>t up joint ventures with MNCs, or to utilize the expertise located in DC 
research universities. Thus, agricultural pesticides, farm machinery, and 
fertilizer were imported or produced under license while plant breeding, soil 
science, and animal science knowledge was secured from universities in DCs or 
for certain crops at the International Agricultural Research Centers (IARCs). 
The changing university-industry relationships in the DCs are threatening to 
disrupt this traditional pattern as both universities and their professors are 
now forming far closer links with industry. For LDCs these new arrangements 
present a number of problems. The foremost is that LDCs may not havE> the 
financial resources to purchase this recently privatized research. 
A TWC must be very careful when it enters the market for technology 
because corporate sellers will quite naturally attempt to extract the highest 
price. Previously, the DC universities were locations where useful knowledge 
could be secured at far lower cost or even gratis. As was illustrated earlier 
this has changed with the commercialization of biotechnology. In many cases 
the university no longer is merely a disinterested institution producing 
knowledge for the public benefit, rather the university and its professors 
have become much more conscious of the possible value of their research. 
These changes have made it important for TWCs to remember when dealing 
with professors in DC universities that the professor's surviv~l is dependent 
upon an ability to attract research money. In biotechnology this money is 
increasingly being furnished by industry. A country wishing to secure 
research from this professor or link with him in a "twinning" arrangement, 
must be aware of how the professor's economic interests may conflict with 
other goals. For example, in the growth of the U.S. biotechnology industry 
useful university inventions have been transferred to companies with t.he 
45 
~allusion of academic personnel (Kenney forthcoming). The dangers can be 
illustratPd in the following hypothPtical case. lf a joint research project 
between a TW scientist and a U.S. scientist leads to a superior method of 
cloning coconut palms, it might be possible for the U.S. professor patent the 
invention secretly. The TW scientist could possibly get the patent disallowed 
in his country, but any products using the newly patented process would still 
be forbidden from entering other countries where the patent was valid. 
Further, the DC professor could sell the products of the work in all other 
countries. Thus, the question of cooperation is no longer a simple decision on 
scientific grounds and academic trust--biotechnology is business. 
Other changes in university-industry relationships are underway. Nearly 
all the good university biotechnology laboratories are being provided with 
major corporate funding ($100,000 or more per annum). In some cases, the 
companies have patent rights, in others, the companies merely wish to 
"observe" the research progress. It can be assumed that if a TW researcher or 
student brings an interesting plant variety for research, it will end up in 
the collection of that company. Knowledge and research materials now have 
value and accordingly attention must be paid to their transfer. 
The small NBFs, however, do provide interesting opportunities for TWCs 
to secure specialized expertise. Contrary to the large MNCs that have very 
strong cash flows and rarely license anything but older, less profitable 
technologies, the NBFs are willing to sell state-of-the-art technology. There 
are a variety of reasons for this willingness, but first and foremost, is the 
fact that these companies need money. Another aspect is that the NBFs believe 
that LDCs will not compete with them in U.S. markets. Whereas if they sell 
technology to an MNC they are providing knowledge to a real or potential 
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competitor. Finally, the NBF's employees are former academics and some of 
these individuals do have genuine concerns about the TWCs. Therefore, it may 
be possible to purchase specific items or knowledge at relatively low cost. 
A number of TW governments and companies have already signed contracts 
with U.S. NBFs (Table 11). If a TW company or country knows exactly what it 
needs and is able to bargain effectively with the NBFs, then a mutually 
convenient arrangement could be established. The types of services these 
companies could render include: the training of TW personnel in scientific 
techniques, contract research, joint ventures, and marketing arrangements. The 
weakness of many of these linkages is that TW scientists would not learn the 
scientific techniques used to create the product. Another possibility is to 
contract the company to provide a turnkey biotechnology facility. However, 
this assumes that trained personnel are available to use, manage, and maintain 
the facility. This section's purpose has not been to recommend such Jinkages 
nor to exhaust the possible types of arrangements. It is important to 
indicate possible strategies for securing information access that are avail-
able due to the new relationships in the DC scientific communities. 
International and Regional Networks 
The promise of biotechnology for development has led to a flurry of 
activity on the part of development organizations. A major aspect of these 
efforts has been to develop information transfer networks. Networking will 
be especially important because it provides a way in which critical masses of 
researchers can be coalesced even though the researchers are in different 
locations. This is also important because many TWCs suffer from sim]lar 
problems and can learn from the knowledge developed in other countries. The 
first UN agency to recognize the importance of the impending revolution in 
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biotechnology was UNESCO which b~gan to organize n~tworks of researchers 
around its MIRCEN (Microbiological Resources Centres). The MIRCENs provide 
nodes through which information is transferred and contacts made. UNESCO also 
provides small grants and arranges training courses for scientists from TWCs. 
The best known international effort in biotechnology is the newly 
approved International Center for Genetic Engineering and Biotechnology 
( ICGEB) founded tmder the auspices of UNIDO. After a long acrimonious debate 
the decision was made to split ICGEB with one site in Trieste, Italy and one 
site in Delhi, Ind1a. The founding of ICGEB leads to questions regarding its 
research ag~nda. Given the nature of biotechnology there are an almost 
infinitely large number of projects that could be undertaken. Should ICGEB's 
aim be teaching, research success, or real products? It will be difficult to 
be successful at any one and they are not necessarily complementary. ICGEB is 
modeled upon the successes of the IRRI and CIMMYT, but both IRRI and CIMMYT 
had specific crops and concrete goals, i.e., to raise TWC grain yields. ICGEB 
does not have such a strong specific goal and therefore may suffer from a lack 
of clear targeting culminating in a diffused and ultimately not very forceful 
effort. 
If ICGEB's agenda is to be agricultural in orientation, then very 
different scientific skills will be required from those needed for an indus-
trial fermentation-oriented research facility. Crop selection would also 
become a political question and it is not clear that ICGEB would be the 
correct location for crop biotechnology research. An item of concern is that 
in case of breakthroughs in producing new plant varieties would ICGEB have an 
outreach or extension program capable of moving the new plants to the field? 
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Also, problematic is the dual campus aspect of ICGEB--securing coop~ration 
between the campuses may be difficult. 
There are a number of other United Nations organizations that have made 
investments in the biotechnology, e>.g., UNESCO, FAO, WHO, ILO, UNDP and UNU. 
This widespread involvement is indicative of the breadth of the coming 
biorevolution and the difficulty of tackling its implications by merely 
discussing, say the farming system. For example, if World Health Organization 
research produced vaccines or pesticides effective against the vectors of 
yellow fever, malaria, and trypanosomiasis, then African agriculture wo1tld be 
immeasurably changed. There are good reasons for all of these organizations 
to be involved. 
International Agriculture Research Center (IARC) 
The IARCs have been important institutions in developing and transferring 
the results of applied plant breeding to TW agriculture. The biorevolution 
will provide new tools to agricultural scientists with which to produce higher 
yielding and stress tolerant varieties. To successfully deploy the new 
techniques will require scientists with skills in areas not traditionally 
associated with agricultural science such as molecular and cellular biology, 
immunology, oncology, and virology. The influx of these scientists will also 
require the IARCs to do research that is more basic than they have tradi-
tionally undertaken. 
The leading IARC in exploring the potential of biotechnology for TW 
agriculture has been IRRI. In April 1984 IRRI hosted the Inter-Center Seminar 
on IARCs and BiotE-chnology and a report was issttE>d making a number of recom-
mPndations regarding potential technical developments of possiblE> interest and 
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usE> to lARCs. The major recommendaUons of the report grouped under 
"Inte-nsification of Coope-rativE> ResE>arch" :includE>d: 
1) Increased twinning of IARCs and advanced laboratories in DCs. 
2) Trilateral linkages between an IARC, a developing country labora-
tory, and onE> in a developed country. 
3) Encouragement of increased scientist-to-scientist interaction 
between IARC scientists and those in biotechnology laboratories. 
4) The organizing of cooperative networks of scientists in numerous 
countries in fields such as tissue culture. 
5) ExchangE> of scientists especially by encouraging visiting scientists 
to fill gaps in internal competence of IARCs (IRRI 1984:27). 
Recommendations under the heading "Institutional Arrangements'' were: 
1) To organize an intercenter seminar on biotechnology every three 
years. 
2) For each center to organize a biotechnology working group to be 
chaired by the d]rector general of the institute. 
3) To include an outstanding cell or molecular biologist as a member of 
the !ARC's Technical Advisory Committee. 
4) To organize training courses in biotechnology for TWCs (IRRI 
1984:28). 
Very obviously, the IARCs will be crucial in transferring the biotech-
nological breakthroughs in thejr designated crops to TWCs. This role will 
require coordination with ICGEB to ensure that duplication of effort is 
minimized. And, in fact, the !ARCs are probably better suited to be lead 
research institutes due to their already very strong crop-specific outreach 
networks. Operating through the !ARCs in diffusing biotechnical knowledg~ may 
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lessen the need for ICGEB to duplicate research already underway in agricul-
ture. The !ARCs fully expect to increasingly use biotechnology to reinforce 
their conventional capabilities (Swaminathan 1982). However, the division of 
labor between the !ARCs and ICGEB has not yet been settled nor have the IARCs 
yet developed the requisite biotechnology expertise. 
Regional Networks 
Another method by which TWCs are attempting to overcome their late start 
and lack of a critical mass of researchers is to form regional networks. The 
UNDP and UNESCO have provided monies for the countries of Argentina, Brazil, 
Chile, Costa Rica, Cuba. Mexico, and Venezuela to organjze a Latin American 
Biotechnology Network. This plan includes the eventual linking of the 
countries through a computer network (Krauskopf 1984:2). There are also plans 
to contract with Latin American laboratories to produce biological research 
materials such as restriction enzymes, oligonucleotides. etc. The production 
of these materials not only provides important hands-on experience, but also 
loosens dependency on DCs and demands for hard currency (Allende 1984). This 
network would be the first TW biotechnology network and will provide oppor-
tunities to strengthen biotechnology in Latin America. The Latin American 
network is being built on the experience amassed from a Latin American biology 
training network and provides an opportunity for developing biotechnical 
knowledge through the collective effort of TWCs. 
International Biotechnology Efforts and Agriculture--Some Thoughts 
Perhaps, for the first time in history TWCs are demanding a role in and a 
share of the benefits of a new technology before rather than after it has be~n 
deployed. This sentiment was best expressed by the late Indira Gandhi (1982) 
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who quo1f'ci Cf'd} Powe>ll -in i'l rf'rf'nt issuP of Srif'nc<->: "Jt WE> Jpft thl" 
development of science in the world to the free play of economic factors 
alone, there would inevitably result a most undesirable concentration of 
science and scif'ntists in too few centres, those rich in science becoming even 
richer, and those poor relatively poorer." To capture the promise of bio-
technology will require a depth of commitment, honesty, and realism that has 
sometimes been lacking among TW science policy makers. But, in contrast, to 
technologies such as nuclear power, satellites, fiber optics, and roboti-
zation, biotechnology offers areas of potentially lucrative research to all 
but the smallest countries and these countries can participate in regional 
biotechnology networks. 
Biotechnology will have incalculable economic impacts over the next 
twenty years and have far-reaching social repercussions. Agriculture as much 
or more than any other human activity will be transformed by biorevolution. 
Biotechniques such as tissue culture can be practiced with only small capital 
investments, yet can yield very real benefits to farmers. Plants that can 
expect little research attention from developed country scientists such as 
tropical hardwoods, could provide handsome economic returns to a country 
willing to invest in research. Similarly, the development and use of microbial 
pesticides could contribute not only to alleviating the costs of imported 
pesticides, but also would be environmentally benign. There are so many 
technologies and so many possibilities in agriculture that choices of research 
goals will need to be made on the basis of rational analysis and not on specu-
lative> pt·omises. 
The increasing role of private industry in biotechnology is beginning to 
control and reroute the formerly free flow of information as professors become 
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increasingly involved in ownership of biotechnology companies. As university 
administrators and professors in DCs become increasingly linked to private 
industry it may become increasingly difficult for TWCs to secure unbiased 
advice from university scientists. The phenomenon of patenting and plant 
variety protection will also serve to block the ability of TWCs to access 
information produced in the DCs. It is paradoxical that in this age of 
information and networking that it is information and knowledge that will be 
increasingly withheld from the poorer countries--even as these countries 
supply the genetic information in the form of germplasm to developed country 
plant breeders. However, in many TWCs patent law is not well enforced and the 
techniques of biotechnology once mastered are relatively simple to repeat. 
Thus, for countries not encumbered with the patenting system many of these 
products may be comparatively easy to produce. 
Private capital sees sectors of TW agriculture as markets for the 
biotechnology products it is developing such as pesticides and seeds. 
However, MNCs will only supply these products to TW farmers with sufficient 
currency to allow the company to make a profit. The product developed and the 
recipient of the product will be chosen without reference to any goal but the 
maximization of profit. Private industry because of its duty to its stock-
holders must necessarily respond to the goal of securing profit for its owners 
regardless of its impact on society. However, for TWCs biotechnology is too 
important to allow narrow self-interest to control its deployment. 
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Biotechnol~A Simple Technical Appendix 
This appendix briefly dPscribes snmP of the more important techniques 
that fall under the broad rubric of biotechnology. Bullet al. (1982:21) 
define hiotechnology as "the application of scientific and engineering 
principles to the processing of materials by biologic agents to provide goods 
and services." The U.S. Office of Technology Assessment (1981:49) also 
attempted a definition: "Biotechnology involves the use in industry of living 
organisms or their components (such as enzymes)." Both definitions are very 
broad and could be interpreted to include a number of activities such as plant 
breeding and traditional fermentation engineering which are not usually 
included in definitions of biotechnology. This document uses the term 
"biotechnology" only to refer to the new biological or drastically improved 
biological techniques that have been developed over the last ten years. 
Older biological terhniques used for production such as plant breeding, 
fermentation and immobilized enzymes will not be replaced by the new biotech-
nology. Nevertheless, the new biotechnologies will deepen our ability to use 
and understand how the traditional biotechnologies operate. Molecular and 
cellular biology are opening up the black box called the cell and explicating 
its operations at a molecular level. Thus, the older biotechnologies will be 
used in rombination with the new biotechnologies and this combination will 
yield new productive innovations. 
Fermentation 
Fermentation can be d~fined as the use of cell metabolism to convert 
inputs into another product(s). Fermentation is a traditional technology on 
the verge of a new revolution in productivity and importance due to the vital 
role of fermentation as the process by which genetically engineered organisms 
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will conduct their production. Many traditional fermentation processes such 
as those that make alcoholic beverages, yogurt, soy sauce, and tofu will be 
made more efficient by the genetic engineering of microorganisms currently 
used. Other processes such as the production of single cell protein from 
agricultural or human wastes will depend on the increasing sophistication of 
fermentation engineering to make them competitive. The success of biological 
production facilities and the survival of many genetic engineering technology 
companies will depend on their mastery of fermentation engineering. As with 
many of the other technologies discussed fermentation engineering can be 
undertaken at many levels of sophistication and what is appropriate for one 
task or environment may be entirely inappropriate for another. 
Molecttlar Biology and Recombinant DNA 
DNA's structure was first correctly theorized by James Watson and Francis 
Crick in 1953. The DNA molecule consists of two strands of base pairs 
stacked upon each other. The ability of DNA to reproduce is because the .four 
bases two pairs can only pair with their complement. Thus, either DNA strand 
can unfailingly reproduce its complement and in cell division and this is 
exactly what occurs. DNA in the form of its genes also contains the program 
which when translated by RNA orders the amino acids that make proteins. DNA 
does two major tasks in the cell--it reproduces by splitting and contains in 
the ordering of the bases the program controlling cellular activities (more 
detailed discussion can be found in OTA 1981; Sylveste~ and Klotz 1984; Watson 
and Tooze 1981). 
The 1960s were a period of intense research activity as scientists worked 
on solving the coding problem, i.e. the translation of the DNA code into amino 
acids. The solution of this problem in the late 1960s combined with discovery 
of various enzymes that could both cut and bind DNA molecules provided the 
possibility of rewriting the genetic program. Simultaneously, other 
researchers had by the early 1970s perfected techniques for inserting foreign 
DNA into bacteria. 
The single experiment and methodology to which the biorevolution can be 
traced was done by Stanley Cohen of Stanford University, Herbert Boyer of the 
University of California, San Francjsco, and their research teams. These 
researchers succeeded in inserting a DNA sequence (gene) into a bacteria which 
then successfully produced the appropriate protein (Cohen et al. 1973). This 
success made it apparent that a bacteria could possibly be induced to produce 
any protein. This was the technical breakthrough upon which the biotechnology 
industry was built. 
The implications of rDNA for agriculture are myriad. As we have already 
seen animal vaccines can now be produced microbially. For example, scientists 
have recently spliced a rat growth hormone into a mouse. The results were 
that the mouse grew to rat size (Marx 1982:1298). This research success 
raises the possibility of producing larger animals for meat consumption. 
Similarly, there may be possibilities of using rDNA to move single gene traits 
from one plant to another. 
The initial impacts of rDNA agricultural inputs will not be in plants or 
animals, but rather by the genetic manipulation of microorganisms that are 
involved in farming systems. Already scientists are proposing to deliberately 
release genetically engineered microorganisms into the environment. For 
example, Steven Lindow of the University of California, Berkeley and Advanced 
Genetic Sciences, a small company, have developed a genetically engineered 
bacteria meant to increase plant frost resistance. The genetically engineered 
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bacteria is supposed to displace the destructive ice nucleating bacterja which 
facilitate ice formation on plants during frosts and thereby prevent frost 
damage (Advanced Genetic Sciences 1983). The simplicity of microorganisms and 
advanced level of skills for manipulating microorganjsms make them the life 
forms that will first be altered by genetic engineering. 
Monoclonal Antibodies 
Monoclonal antibodies (MCAs) are the product of a hybridoma. Hybridomas 
are formed when an antibody producing cell and a cancer cell are fused. A 
successful hybridoma acquires high rate of reproduction from the cancer cell 
and the antibody production capability from the other cell. The hybridoma 
quickly multiplies and each cell becomes a producer of an identical antibody. 
Antibodies are commercially important because an antibody can target very 
specific, unique chemical structures termed antigens. If an antigen can be 
identified as an indicator of a physical feature such as say, cancer, the 
antigen's presence in a sample can be identified by using a monoclonal 
antibody, hence the antibody is a highly specific diagnostic. 
In medicine the usage of MCAs is growing very rapidly. Hepatitis, 
giardia, pregnancy, and cancer test kits have already been marketed and many 
others are being developP.d. Veterinary applications of MCAs seem fairly 
routine and can be expected for diagnosing or treating high value animals such 
as horses, cows, and pigs. Companies such as DNA Plant Technologies are 
experimenting with ways of using MCAs to diagnose plant diseases in high value 
plants such as trees. For example, IRRI is considering MCA use to identify 
rice viruses indistinguishable with current tools (Hibino 1984). The 
appliC'ation of MCAs to agriculture will not be enormous, but H wj ll provide a 
useful tool for certain unique applications. 
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Plant Tissue Culture 
Tissue culture refers to the ability scientists have developed of 
sustaining living cellular material in an artificial environment, i.e. in 
vitro. The science of tissue culture is quite old, e.g., PTC was initiated in 
the 1920s (Sandahl et al. 1984). In the intervening year, not only have 
tissue culture techniques improved immensely, but so has understanding of 
plant cell physiology and genetics. In the last ten years researchers have 
discovered many new and possibly commercial applications for tissue culture. 
For the sake of brevity and because the focus of this report is agri-
culture, animal cell tissue culture is omitted from consideration (though it 
is critical for tasks such as MCA production). PTC has evolved in two very 
different directions: First, and most important is the potential for 
improving the traditional plant breeding process. PTC will impact plant 
breeding in a number of ways, such as speeding the production of new plants, 
providing better quality germplasm, i.e. virus-free potatoes, and incorpor-
ating more genetic variability into the breeder's programs and possibly in the 
long-term, eliminating the need for elaborate crossbreeding. The second 
thrust in PTC is towards biosynthesizing valuable plant phytoproducts in 
vitro. 
Ti.ssue culture for plant improvement is not one single technique rather 
it subsumes a number of techniques with very different levels of sophisti-
cation involved in their practice. The simplest technique is the duplication 
of plants through vegetative propagation. This technique is possible because 
certain plants such as potatoes, cassava and orchids, among others, can be 
propagated from microcuttings. In vitro propagation increases the speed of 
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reproducing new plants and if properly undertaken can assist in the elimina-
tion of plant viral diseases. Vegetative propagation using PTC is a proven 
technology that can be used for the large-scale reproduction of a number of 
species. 
Embryo rescue is another PTC technique that is receiving increased 
attention. Embryo rescue was developed to save plant embryos that normally 
would abort due to sexual incompatability. These embryos contain sexual mixes 
not normally available to plant breeders and are used to incorporate inter-
esting traits into agronomically important varieties. These techniques are 
already being used for tomato, cotton, bean, banana, and indica rice varie-
ties. Embryo rescue cannot overcome all types of sexual incompatability and, 
therefore, its use is limited. 
A more powerful technique, anther culture, actually was invented in India 
and has been effectively exploited in China for producing new rice and wheat 
varieties (Zapata 1984). Anther culture allows the fixation of desired 
characteristics much more quickly thereby reducing breeding time significantly 
(Evans et al. 1983). For example, breeding time for a new barley variety was 
reduced from twelve to five years through the use of anther culture (Kasha and 
Reinbergs cited in Evans et al. 1983). Already an International Rice Research 
Institute anther-cultured cold-tolerant rice variety is being field tested in 
Korea (Zapata 1984). Anther culture not only quickens the breeding cycle but 
also facilitates crossing domestic plants and their wild relatives thereby 
incorporating new material into the gene pool. 
Other important techniques include protoplast fusion, a technique that 
allows the protoplast (cellular material) of two widely djffering cells to be 
completely fused. The result is a cell that contains aspects of both cells 
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and, in an increasing numb~r of instances, a whole plant can be regenerat~d. 
So, for example, researchers have produced a "pomato," a plant that has roots 
r~sembling a tomato plant and stem and leaves resembling a potato plant. 
Protoplast fusion is a technique that makes possible a mixing of genetic 
material from widely differing sources. It also makes for a much more 
thorough mixing than is possible with conventional sexual means. However, 
this technique remains at an early stage and should improve greatly as it 
attracts more research interest. 
It is paradoxical that PTC first focused on producing exact clones, but 
it was soon discovered that the tissue culture process created variation, 
i.e., not all the clones were identical there was what is now termed soma-
clonal variation. Initially, somaclonal variation was considered a problem, 
but later scientists recognized this as a source of possibly useful genetic 
variability. For example, researchers discovered that certain variants 
actually had superior disease resistance to their parent plants (Evans et al. 
1983:495-496). The causes of somaclonal variation are not yet fully under-
stood even though it is already being used in commercial plant production. 
PTC for plant improvement encompasses many techniques some of which can 
be used in very low budget environments. PTC technology is readily available 
in the scientific literature and a large aspect of success in PTC research is 
trial and error. Various parameters such as media, temperature, and other 
environmental factors must be varied to achieve practical success. Because of 
the "craft" and labor-intense nature of much PTC it offers great opportunities 
for success to TW plant scientists. 
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Industrial Tissue Culture 
Certain plants produce rare, high value products which are termed 
secondary metabolites because they are not absolutely necessary for cellular 
growth {those necessary plant products are termed ''primary metabolites''). 
Often the secondary metabolites are produced by sp~cifjc types of cells, e.g. 
root, bark, flower petals. PTC makes it possible to grow and harvest these 
secondary metabolite-producing cells in vitro. In fact, scientists have 
succeeded in inducing these cells to biosynthesize up to ten times greater 
amounts of the desired compound (Yamada 1984). Other ongoing PTC research 
concerns designing a suitable mass production fermentation process, preferably 
continuous (Kenney et al. 1984). 
Bioinsecticides 
The recent controversies regarding the environmental costs of using crop 
protection chemicals combined with price increases has encouraged university 
scientists, government officials, and chemical company r~searchers to invest-
igate the efficacy of naturally produced insecticides and herbicides in a 
griculture. The biocides can: l) draw upon natural chemicals that plants 
produce to ward off predators, 2) use products of a predator's own hormone 
system to interfere with its normal activities, e.g., th~ use of an insect sex 
hormone so as to interfere with that insect's reproduction, and 3) draw upon 
the increasing number of bacteria and viruses that prey upon plant predators, 
e.g. Bacillus thuringiensis controls upon a number of commercially important 
insects (for detailed discussion, Orrego 1981). 
The principles behind biocide use is that in nature plants and micro-
organisms are in a constantly evolving competition. Researchers are attemp-
ting to use nature's own weapons against agricultural pests. For exampl~, 
hl 
h'lrtt=>riR ::~rp \1"1Pd to intt->C't ,<mci ki II itHH-•rts int@ost inr; R t1t=>lrl, l.P., rrt=>att=> R 
dis~asP f>pidt=>mic in fin unwantMi group ot 1nsPrt!'l. 1\s R honus, thP hartPria 
~xp1r~ whPn thPY h~vP no mnrP hosts, tht1s PltminRt in~ thP prohl~m ~xpPriPnr~rl 
with chemical pPsticides which tend to linger in the envjronment. Other 
pJRnts prorlt•re chemicals that discourage plant growth (allelopathic) creating 
"livjng'' spacp around thPmsPlves. ThPst=> genetic traits might be very useful 
in rrop plAnts. The emphasis of this type of research js to harness natural 
torres to man's needs. 
There can be no doubt that the entire field ot biocides is only in its 
inf~ncv Anrl will surely grow during the next decade. In the case of us~ful 
bactPrial and viruses the research etfort need not be highly sophisticated and 
can be ronductPd hv tt=>ams of entomologists and microbiologists. For examplP, 
a number ot LDCs h,we de-vel oped ~acj} __ lt1s thuringiensis preparations for use 
agajnst their partirular inst=>ct problem. The entire field of bioinsecticides 
(and integratPd pPst manaBement) offprs gr~at potential for significantly 
lowPring the costs ot pe-sticide ]mports while decrPasing environmental 
damagP. 
!!~ L_E_P.;it'~ 1_ ~itr __ og~'>n _ F~ '!_~tj Ol!...._i_ BNF L 
BNF has rPceived mu<'h attention in thP last ten years because ot the 
enormous ~osts farmer$ arP incurring in the purrhase of nJtrogen fertilizer. 
Tn the case of nitrogen. the problem is not that there is insufticient 
nitrop,en (80 percent of thP atmosphere is nirrogen), but rather its chemical 
form makf>s it unavailable tor plant use. However, there are strains ot 
bacteria and algae th~t can convert atmosphPric nitrogen 1nto a form usable by 
plants, this pro~ess js tPrmed nitrogen fixation. The value of nitrogen fixed 
by legumP symbionts has been estimatE>d as worth nearly $10 billion in l..I.S. 
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agriculturE> alone (OrrE>go 1981:">1). Soybeans arE> the most valuablP lE>gttmP 
crop but others inrlude: pea, clover, alfalfa, anrl peanut. ThE> barteria live 
in root modules and are provided with nutrients by the plant's vasrular system 
and in return provide fixPd nitrogen to the plant. lnrrPased resParch is 
underway to discovPr bacteria-sovhean combinations that will be more eftE>r-
tive at fixing nitrogen. 
Svmbiotic nitrogen fixation does not take place in thP mainr ~rain 
crops--the very onPs that ronsume the bulk nf the nitrn~Pn fPrtil1zer. Much 
research is currently underway trying to develop grains that will fix nitro-
gen. However, this i.s a long-term goal berause not Dilly mttst the plants he 
engineered to harbor the bacteria, but bacteria must also hP developed to 
thrive in the symbiosj s. This nE>cessitatE>s rontro lli np; the> behavior ~!:ld 
interaction of two very different organisms--a much more difficult task than 
engineering either one. AnothPr difficulty is the fact that nitrogPn fixation 
is a very energy-intensive operation. If this energy is withdrawn from P,rain 
formation, then the value of the yield lost due to energy diversion may be 
higher than the value of nitrogen fertilizer saved. ClearJy, the promise of 
self-fertilizing grain crops has major hurdles to overcome. 
Another area of very active research is to improve the capability of freE> 
Jiving nitrogen fixing bacteria. These bacteria sPct1rP energy from derom-
posing matter and fix nitrogen into the soil. Research is directed to making 
these more efficient and encouraging their growth in the plant's rhizosphere 
so that it can utilize the newly fixed nitrogen. 
The final area of research is the blue-green algae that Live in the 
flooded rice paddy fields and can contribute 38-80 kg/ha/year to thP total 
quantity of natt1rally fixed nitrogen in the paddy ( OrrPgn 19Rl: 57). ThE> 
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returns for thE> investmPnt. CurrPnt rPsearch is focusing on the selection of 
variPtiPs that can ti .. highe>r limountA of nitrogen and thdve> in arE>as outsirll" 
thP plant's normal range. Another effective technologv for nitrogen fixation 
is provided hy the symhiotic relationship hetween a blue-~reE>n algae and the 
Azolla fern. In Caljfornia Azolla has been introduced into paddy fields and 
is provi.rling up to 75 perrPnt of thP paddy's totaJ nitrogen requirements 
(OrreP,o 1981:58). For rice paddy culture thpse are very promising methods of 
decr•asjng the costs of nitrogen fertilizer ltSe> (Swaminathan 1982). 
l<'ootnnt<>'l 
l) Many of the argumPnts in the monograph have been mArl~ in Kenney (198~1. 
KennPy et al. (1983), Kenney et al. (1984), KennPy and Buttel (1985), 
Buttel et al. (forthcoming), and Kenney (forthcoming). 
2) The .Japanese biotechnology effort will be very important in interndtional 
competition (Katzenstein and Tanaka 19841. Also, some European companies 
will be important biotechnology competitors IOTA 1984). 
~~ The chemiral/pharmaceutical companjes prominent in biotechnology and the 
Third World include: Abbott LaboratoriPs (U.S.), American Cyanamid 
(ll.S.), BASF (Germany), Ciba-Geigy (Switzerland), Dupont (U.S.), Hocchst 
(Germany), Hoffman-LaRoche (Switzerland), ICI (Great Britain), Merck 
(U.S.), Monsanto (U.S.), Pfizer (U.S.), Rhone-Poulenc (France), Rohm and 
Haas (U.S.), Sandoz (Switzerland). 
4) Five to ten years is an estimate. For rompanjes using monoclonal 
antibodies the rle1ay until a marketable product emerges could be as short 
as two to three years. Positive cash flow for the NBFs may even take 
longer for some companies. Other companies such as Genentech have been 
abl~ to r~main near hreakeven since inception due to their research 
contl.·acts. Tht'>re have also been a few NBFs formed in Europe. Most 
prominently, in the United Kingdom there are: Twyford Laboratories, 
Celltech, and Agritech; in France, Tran~ene, and the Swiss-American 
hybrid, Biogen. 
S) It should be noted that ClMMYT (the International Center for Maize and 
Corn Improvement in Mexico) is also cooperating with the University of 
II Linois on corn improvement. 
b) Biotechnology will in all likelihood facilitate the growing integration 
of thE> chE>mical and pharmaceutical industries in the U.S., i.e., a 
pharmacPutical is no more than a chemic:'ll compound or mix of compounds 
that must he producPd in Jess bulk and under more ri?,orons standarrl.s. 
The clesirable aspects of the pharmaceutical industry are that the 
prodttrts are usually patented, have higher markups, anrl lesser quantities 
are produced usually with less pollution. 
The star,nation in the rhemica] industry with the exception of 
specialty and agricultural chemicals has induced U.S. MNCs to emulate 
European MNCs su('h as Sancl.oz, Hoechst, and Ciha-Geigy that a:ee already 
integrated. Similarly, the pharmaceutical MNCs are moving into specialty 
and agriculttlral chemicals--an area ot patent protection and high 
profitability. 
7) It should he noted that yield in a farmer's field is not a simple 
concept. YiE'ld mttst be realizable, i.e., the grain mt1st be harvestable. 
Therefore, pest-resistance, drought-tolerance, and lodging-resistance arE> 
all aspects of the yieJd equation. Thus, yield increase also means loss 
minimization rlue to environmental factors. This leads to the economic 
viability of pesticide t1sage, etc. 
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Rl This is a hotlv debated isqup with traditional plant breedPrs takin~ 
stronr.; e-xreption to this VlPWpoint (SprAgue Pt ,;d. 1Y80l. 
91 It is already the case thar most hybrid SPPd used in Brazil, Ar~entina 
and othP·r TWCs is either lmportMl from developed <'onntri es or 1'\Perl 
production in the TWC is controllt>d bv a MNC. CompaniPs hPavily involved 
in this husiness inrJuctP PionPer, De Kalb, Sandoz, Ciba-GPigy, Upiohn, 
and Shell. 
10} This process of shitting tne puhlic resParchers out of tields in whirh 
private industrv feels it <an commercially exploit is a longstandin~ 
pattern in thP U.S. And, in fact, is oncp again underway in thP ll.S. 
aRricultural universities with rPference to pubJic seed release 
!Kloppenburg and Kennev l9R3). 
ll} In the U.S. the artitiriallv high price of sugar duP to quotas and 
protectionism has certainlv assisted in remainin~ viable. On the othPr 
hand, HF<'S would -probablv he ;qhJ!'> to survive w:i thnut the quot.:~s. The 
s11garbePt ind11str·v would fw dPl'.troyed. 
12) RPproductive technologies 1ppJied to swine are far behind the work with 
cattle, but lmmunogenPtics ( 1983) claims to have d~?veloped ft·Pezing 
procedures for swine embryos. 
1 i) CelJ tissue ctt] ture is possible tor either pJ ant or animal re ll s, hut for 
discussion focused on farming systems animal celL rulture is unimportant 
excE>pt for thP purpose of prodt1dng monoclonal antihodiPs {MABs) to be 
used for either treatment or diagnostic purposes (tor example, the 
Mole-cular (;enetirs, Inc. scours vacrine c-ontains MABs). ThPrefot·e, this 
section will be entirely dPVOtPd to plant tissue culture IPTC) for 
production of valuable phylochemic-als. 
14) It is recoKnized that this phased implementation might be verv ditticult 
in LDCs St1ffl'>ring from recurri..n~ foreign exchange problems whirh ron-
sistently disrupt loans. However, the other choice which is to order 
everything needed for the tirst five years immediately results jn muc-h of 
the equ:ipm~nt deterioratin~ h~fore it is ~v~r used. 
1~) Orrego 11983) rites figures indicating that very tew of the world's 
practicine microbiologists are located in thP TW. In examininp, a lf.S. 
NTH training program for Latin Americans Or rtf' go ( 198 3:6) cal ct1lates that 
the "brain drain" to the U.S. "has varied from country to ronntr·v: none 
for Brazil, ~5% for Chile, 6% tor Colomhia, 2% for Mexico, and 691 tor 
Uruguay. Finally, a sut·vey of the memberships ot the Internation<'l) 
Association ot Plant Tissue Cult11re Association indicates that 69 
countries ar~ represented, but again the vast maiority of the scientists 
are located in DCs with the exception of India and China. However, 
tissue culture is an area of increasing TW involvPment (Sondahl 1984). 
lb) The Indian National Biotechnology BoArd 11981) has tormerl an advisory 
committee that inclt1des: DL Narang, CanAdian N<ltional Researr'h Council; 
Dr. Ananda Chakrabarty, llnivo?rsity of Illinois; Dr. Inder Ver·ma, Salk 
hh 
ln~titutP tor BiologirRl SriencPs; Dr. SRtvabarla Nandi, Director, Canrer 
KP:-;P.~rrh fnstitutP, l'niv~'>rsitv ot <'Alitornia; Dr. 0. P. RRh], Ch~irm11n, 
ll~'>p.trtmPnt l)f l,iff> SriPnc-Ps, llnivt->ndtv ot NPW Ynrk; !h". 1\. VPni<Rta-
suhr~m~ni<~n, IIPTHr·tm ... nt ot ChPmiPal ~nd Bjolop,i.C'"l Fnp;i.nPPrinp,, H11tgPrs 
llni.vPrsHv; Dr. Samhhunath <;hosh, Manager, Bioengineering ResE>srch, 
lnstitutP of Gas TPrhnology. The ability to tap scientists of this 
caliber is an important strength for the Indian biotePhnology program. 
17> The level of interest of Indian companies may be relatively high iurlgjng 
trom the fact that Tata Co. has Pntered a joint venture agreement with 
Kvowa Hakko Co. (Japan), Sumitomo Trarling Co. (Japan) and Native Plants 
lnc. (USA) forusi.n~ on using hiotechnology for tropiral crop improvement 
(Tanr~.ka 1983b). 
Tdble 1 
MIT Biology Department Faculty and Corporate Affliations 
Professor 
David Baltimore 
Eugene Bell 
David Botstein 
Herman Eisen 
Gerald Fink 
Har Gobind Khorana 
Harvey Lodish 
Irving London 
Salvador Luria 
Alexander Rich 
Paul Schimmel 
Philip Sharp 
Susumu Tonegawa 
David Housman 
Leonard Guarente 
Source: Kenney (forthcoming) 
Corporation 
Collaborative Research 
Damon Biotech 
Collaborative Research 
Damon Biotech 
Collaborative Research 
Damon Biotech 
Damon Biotech 
Damon Biotech 
Rep ligen 
Repligen 
Rep ligen 
Biogeo 
Damon Bi1)tech 
Integrated Genetics 
Biotechnica Internationa. 
Table 2 
Agrigenetics Consultants 
Consultants 
\volfgang Dietzgen Bauer 
Andrew Binns 
Nicholas Brewin 
Adrienne Clarke 
Peter Dart 
Leon Dure, III 
Elizabeth Earle 
Peter Gresshoff 
Thomas Guilfoyle 
Richard Halick 
~1aureen Hanson 
Huake Hennecke 
Thomas Hodges 
Paul Kaesberg 
Brian Larkins 
Sharon Long 
Alfred Puhler 
Ralph Quatrano 
Barry Rolfe 
John Shine 
Jack Widhalm 
Source: Agrigenetics 1983:23. 
Institutional Affliation 
Charles F. Kettering Research Laboratory 
University of Pennsylvania 
John Innes Institute 
University of llelbourne, Australia 
Australian National University 
University of Georgia 
Cornell University 
Australian National University 
University of Uinnesota 
University of Colorado 
University of Virginia 
!1ikrobiologishes Institut der Zurich 
Purdue University 
University of Wisconsin 
Purdue University 
Stanford University 
University of Bielefeld 
Oregon State University 
Australian National University 
Australian National University 
University of Illinois 
Table 3 
Agricultural Biotechnology Venture Capital Firrus: Principal University-Based Researchers, Financial 
Linkages, and Areas of Research.* 
Principal University-Based Researcher 
____ Company and Researcher's University Affiliation Financial Linkages Areas of Research 
Agrigenetics 
Advanced Gen-
etics Science 
lnl~rnational 
Plant Research 
Institute 
Zoe con Corp. 
Cal gene 
Genetic Engi-
neering Co. 
Dr. Timothy Hall, Univ. of Wisconsin 
Dr. John Kemp, Univ. of Wisconsin/USDA 
D~. Lawrence Sogorad, Harvard Univ. 
Dr. Shepard, Kansas State Univ. 
Formerly Dr. Hartin Apple, Univ. of 
California, San Francisco 
Dr. Peter Carlson, Michigan State Univ. 
Dr. Raymond Valentine, Unlv. of 
California, Davis (present status unclear) 
Dr. Edwin Adair, Swedish Medical Center, 
Denver, Dr. Thomas Wagner, Ohio Univ. 
DNA Plant Tech- Dr. William Sharp (Campbell Soup Co.) 
nology Co. Dr. David Evans (Campbell Soup Co.) 
Holecular Dr. Burle Gengenbach, Dr. Ed Green, Dr. 
Genetics Ron Phillips, Dr. Joachim •Iessing, all 
of Univ. of Minnesota 
Henry Ford and Roths-
child Families 
Pioneer Group, Claeys-
Luck 
Rohm & Haas 
Davy-HcKee Corp. 
Eli Lilly (contract) 
Trans KB 
Sandoz (formerly Oc-
cidental Petroleum) 
Allied Chemical (204) 
Campbell Soup (40%), 
Koppers Co., John Brown 
& Co., Schroder Bank 
American Cyanamid, Smith 
Kline, U.S. Dept. of 
Defense 
Seed-related biotechnol-
ogies 
Cloning of disease-
resistant potatoes 
High yielding potatoes, 
saline-resistant wheat, 
virus-free cassava 
Soybean and cotton 
breeding 
Plant genetics 
Animal genetics 
Tomatoes, tobacco, 
forestry products 
Corn, scours prevention, 
and nonagricultural 
applications 
*All information is accurate to the best of our knowledge, but it should be kept in mind that the proprietary 
nature ot these firms makes it difficult to keep abreast of the latest data. 
Source: Buttel et al. 
Table 4 
Monsanto -- Anatomy of a Biotechnology Companv 
In-House Investment 
--$185 million invested in biological sciences research ~enter 
Biotechnology Companies (Equity Investments and Important Contracts) 
Collagen -- artificial bone powder 
Biogen -- tissue plasminogen activator 
Genentech -- bovine growth hormone 
Genex -- venture capital investment 
Biotechnica International -- B. subtili$ protein expression 
University Contracts 
Harvard University biomedical research ($23 million) 
Washington University-- biomedical research ($23 million) 
Rockefeller University -- photosynthesis research ($4 million) 
Oxford University-- sugar chains ($1.5 million) 
Seed Company Subsidiaries 
Jacob Hartz Monsanto Seed 
Hybritech Seed Co. Farmers Hybrid Co. 
Fertilizer 
5th largest U.S. producer of nitrogenous fertilizers 
Pesticides 
58% market share of grass herbicides market in corn {1978) 
Roundup -- revenues of $500 million 
Lasso -- revenues of $200 million 
(Source: adapted from Buttel et al. 1983) 
Corporation 
Monsanto 
Chevron 
Pfizer 
ARCO 
DuPont: 
Table 5 
In-House Corporate Life Science Research: Description and 
Location.* 
Area of 
Interest 
Agriculture 
Agriculture 
Agriculture 
Agriculture 
Life scien-
ces 
Description 
$40 million invested 
in research 
$38 million 
facility 
20 Ph.D. 
researchers 
15 scientists, 
57 employees 
$85 million 
investment 
Location 
~lissouri 
California 
Missouri 
California 
Delaware 
*These data are presented for illustrative purposes only. Other 
companies that have important in-house agricultural research 
activities include Eli Lilly, Sandoz, and Ciba-Geigy. 
Table 6 
Average Yields per Acre (in the U.S.) in 1930 and 1q75 
(from Agricultural Statistics 1930 through 1975* 
---
Crop 1930 1975 Unit percent increase 
\.Jhea t 14.2 30.16 bushels 115 
Rice 21.0 45.6 cwt. 117 
Corn 20.4 86.2 bushels 320 
Oats 32.2 48.1 bushels so 
Barley 24.0 44.0 bushels 85 
Grain sorghum 10.8 49.0 bushels 358 
Cot ton 15 7. 0 453.0 pounds 188 
Sugarbeets 11.9 19.3 tons 62 
Peanuts 659.4 2565.0 pounds 295 
Soybeans 13.4 28.4 bushels 112 
Potatoes 65.9 251.0 cwt. 311 
Tomatoes 61.0 166.0 cwt. 172 
Alfalfa 1.95 2.87 tons 42 
Source: Sprague et al. 1980:17. 
Table 7 
Possible Applications of Biotechnology Research to Rice Improvement 
Research Technique 
Tissue and cell culture 
Induction and selection of 
useful mutants at the cel-
lular level 
Embryo culture 
Anther and pollen culture 
Protoplast fusion 
Genetic Engineering 
Source: Swaminathan 1982:969. 
End Result 
Salt tolerance 
Aluminum toxicity tolerance 
High lysine and high protein 
Low photorespiration 
Disease resistance 
Low oxygen tolerance 
Intra- and interspecific hybrid-
ization 
Reducing breeding time 
Interspecific and intergeneric 
hybridization 
Hybrid rice improvement 
Azolla improvement 
Incorporation of nitrogen-fixing 
genes 
Table 8 
Multinational Corporations, Product Lines, and Seed Company Subsidiaries* 
Multinational 
Parent 
Sandoz 
(Switzerland) 
Shell 
(UK/Netherlands) 
CIBA-Geigy 
(Switzerland) 
Celanese 
(USA) 
Cargill 
(USA) 
Occidental 
Petroleum 
(USA) 
Primary Products 
pharmaceuticals 
oil, chemicals 
pharmaceuticals, 
chemicals 
textiles, 
chemicals 
grain marketer 
oil, 
petrochemicals 
Seed Subsidiaries 
Ladner Beta Seed (Canada) 
Zaadunie (Netherlands) 
Northrup King (USA) 
Rogers Brothers (USA) 
National-NK (USA) 
Sluis en Groot (Netherlands) 
International Plant Breeders (UK) 
Comanie General de Semillas (Spain) 
Rothwell Group (UK) 
Interseeds (Netherlands) 
IPB Japan (Japan) 
Nickerson P. Gmbh (West Germany) 
Zwaan (Netherlands & Belgium) 
North American Plant Breeders 
(USA; with Olin Chemical) 
Funk Seeds International (USA) 
Stewart (Canada) 
Louisiana Seeds (USA) 
CIBA-Geigy Hexicana (Me xi co) 
Celpril (USA) 
Moran (USA) 
Joseph Harris (USA) 
Nugrain 
ACCO (USA) 
Dorman (U~A) 
Kroeker (Canada) 
PAG (USA) 
Ring Around Products (USA) 
Excel Hybrid (USA) 
Missouri (USA) 
Moss (USA) 
*All information is accurate to the best of our knowledge, but it should be kept 
in mind that the proprietary nature of these firms makes it difficult to keep 
abreast of the latest data. 
Source: adapted from Buttel et al. 1983 
Table 9 
Animal Disease Vaccines Being Developed Using Biotechnology* 
Vaccine 
Bovine scours 
Porcine scours 
Foot and Mouth Disease 
Porcine Parvovirus 
Pseudorabies 
Bovine viral diarrhea 
Bovine adenovirus 
Infectious bovine rhinotracheitis 
Rift Valley Fever 
Company 
Molecular Genetics Inc. 
Cetus 
Cetus 
Molecular Genetics Inc. 
Genentech 
Biogen 
Molecular Genetics Inc. 
Molecular Genetics Inc. 
Molecular Genetics Inc. 
Molecular Genetics Inc. 
Molecular Genetics Inc. 
Molecular Genetics Inc. 
Molecular Genetics Inc. (under 
contract from the U.S. Department 
of Defense) 
* These data are accurate to the best of the author's knowledge, but do 
not constitute a recommendation or evaluation of efficacy. 
Source: Author's compilation from various sources. 
Product 
Opium 
Cinchona 
Digitalis 
Ginseng 
Table 10 
Plant Product Tissue Culture: Performing Corporation and 
Country of Origin.* 
Company 
Plant Science 
Plant Science 
Plant Science 
Plant Science 
(UK) 
(UK) 
(UK) 
(UK) 
Country of Origin or 
Cultivation 
Turkey, Thailand 
South America, Indonesia 
United States, Korea 
Catharanthine Institute for Biotech-
Pyrethrum 
Tobacco 
Murasaki 
no logy Research (Ger) 
Biotec (Bel) 
Japanese Salt and 
Tobacco Monopoly 
Mitsui Petrochemical 
(Jap) 
Kenya, Tanzania, Uganda 
United States 
Japan, Korea, China 
*These data are presented for illustrative purposes only. 
Source: Buttel et al. 1983 
Tah!P ll 
Examples of Cooperative BiotPrhnology Eftorts Between 
Less Developed and Developed Countr1es* 
Less DPveloped 
Country Small Company Area of Research ------~--~~--------------------~--~~--------
Malaysia (Sime Darby Berhad) International Plant Research 
Institute (liSA) 
Argentina Molecular Genetics (USA) 
ChinA Biogen (Switzerland) 
China Biotech Research Labs (USA) 
China Promega Biotech (USA) 
Korea (Cheil Sugar Co.) Eugene Tech, Inc. (USA) 
Korea (Lucky Limited) Chiron Corp (llSA) 
India (Tata Ltd.) Native Plants Inc. (USA) 
Brazil DNA Plant Te-chnologies (USA) 
*Data accurate to best ot author's knowledge. 
plantation crops 
testing FMD 
vaccine 
interferon 
monoclonal antibody 
diagnostics 
enzymes and 
reagents 
interfe-ron 
interferon 
tea, coffee, cocoa 
improvement 
sugarcane and 
coffee improvement 
Reff'rences 
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ANU Reporter 
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